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Abstract 
 
Mycobacterial infections are responsible for some of the most well known disease, 
including Tuberculosis. Reported cases of infections caused by mycobacteria that are 
becoming increasingly resistant to traditional antibiotics are on the increase. This calls for 
a new approach in developing new drugs that can act on novel antimicrobial targets. One 
such alternative involves the use of bacteriophages and the study of how they interact 
with their hosts. Their diversity also suggests that there are many different phage-host 
interactions acting on multiple targets that are currently still unknown. Eight phages were 
isolated and characterized. Genomic libraries were constructed on four of these phages 
and screened for antimicrobial activities using Rhodococcus erythropolis. Six clones 
were further analyzed, and 15 ORFs were predicted with 8 ORFs being assigned 
functions. These genes with similarity to proteins in the database suggest that they are 
involved in membrane integrity and DNA metabolism. These clones were further tested 
on Saccharomyces cerevisiae to determine whether they have any effects on eukaryotes. 
The lack of inhibition in S. cerevisiae suggests these phage products are confined to act 
only in bacteria after millions of years of co-evolution with their host counterparts, and 
further studies into these genes will continue to shed light on bacterial genomics.  
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1. Introduction 
 
1.1 Mycobacterium 
 
The genus Mycobacterium belongs to the family Mycobactaeriaceae, classified with 
Actinomycetes in the order of Actinobacteria. Mycobacteria are aerobic, acid fast/Gram 
positive, non-spore forming and non-motile bacteria (with the exception of 
Mycobacterium marinum). Mycobacterium has been the subject of much research due to 
the bacterium causing two serious and wide-spread infectious diseases: leprosy 
(Mycobacterium leprae) and tuberculosis (Mycobacterium tuberculosis in humans) as 
well as Mycobacterium bovis in cattle.  
 
1.2 Tuberculosis 
 
Tuberculosis (TB) is a major worldwide infectious disease that is concentrated in certain 
parts of Asia and sub-Saharan Africa (Zignol et al 2006) mainly caused by the bacillus 
Mycobacterium tuberculosis with some cases caused by M. bovis and M. africanum 
(LoBue et al 2010). M. tuberculosis was first identified as the causative agent of TB by 
Robert Koch in 1887, and individuals are infected by inhaling aerosol droplets that can 
contain as few as 1 – 3 bacilli. However, the immune system in a healthy individual, 
given several weeks, will most likely to control bacterial replication and spread, resulting 
in almost all infections becoming latent infections with only 5% of the infection 
developing into an active infection (Glickman and Jacobs 2001).  
 
1.3 Use of Antibiotics 
 
Antibiotics are antimicrobial compounds that have a low molecular weight and have been 
used widely starting in the 1940s. They target essential components of the cell machinery 
such as DNA and RNA synthesis, various cell proteins and the cell wall, thereby either 
inhibiting or killing the cell. For TB, the antibiotic treatment involves administering 
drugs isoniazid, rifamycin, and ethambutol for two months before continuing with 
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isoniazid and a rifamycin for another four. Should TB be drug susceptible, then the 
treatment has a 95% success rate (Koul et al 2011). But as both the use and misuse of 
antibiotics became more common and widespread, the world has seen an emergence of 
antibiotic resistance bacteria which includes M. tuberculosis. 
 
Table 1.1 Anti-mycobacterial drugs and their year of discovery. (Adapted from Nguyen 
and Thompson 2006) 
First line antibiotics Year of discovery 
Isoniazid 1952 
Rifampin 1966 
Pyrazinamide 1952 
Ethambutol 1980 
Rifapentine 1965 
Second line antibiotics  
Cycloserine 1952 
Ethionamide 1956 
P-aminosalicylic acid 1946 
Streptomycin 1944 
Amikacin 1972 
Kanamycin 1957 
Capreomycin 1963 
Levofloxacin 1986 
Moxifloxacin 1996 
Gatifloxacin 1992 
 
1.4 Antibiotic Resistance 
 
The misuse of antibiotics has resulted with TB being a recurrent problem, especially in 
the developing world. Moreover, most of the first and second line antibiotics used today 
were discovered and introduced about forty years ago (Nguyen and Thompson 2006). 
With the emergence of antibiotic resistance mycobacterium, the situation is now made 
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much more complicated and requires a need to discover both new cell targets and 
antibiotics to act upon them. There are two types of resistance: The first type of resistance 
involves the two of the main first line drugs isoniazid and rifampicin, this degree is 
known as Multi-Drug Resistance (MDR-TB). The more resistant type is the Extensively 
Drug Resistant tuberculosis (XDR-TB) which has the same resistance of MDR-TB as 
well as any second line TB drugs such as kanamycin or amikacin and also any 
fluoroquinolone (Koul et al 2011).  
 
The emergence of drug resistance is rapidly reversing the gains antibiotics have made as 
more new cases of MDR and XDR-TB emerge. It is estimated that there will be about 9.8 
million new cases of TB in 2011, most of them in developing countries where resources 
are poor and the effect of health care limited (Dye and Williams 2010). With the spread 
of the human immunodeficiency virus (HIV), the reactivation of TB from a latent 
infection to that of an active one is rapidly increasing in these immunocompromised 
individuals. A quarter of all HIV positive patients die of TB and about 80% of these HIV-
TB co-infections are located in Africa (WHO 2010). Furthermore, co-infected patients of 
both TB and HIV experience severe complications in their treatment regime. This is due 
to an increase in the amount of pills taken and thereby an increase in drug-drug 
interaction which leads to a decrease of overall effectiveness of drugs and could lead to 
health concerns in regards to side effects involved (Koul et al 2011).  
 
The increase of cases of resistant TB not only increases the chances of failure of 
conventional treatment, but also ensures the persistence of a more virulent strain within a 
community and in turn increases the risk to uninfected individuals by exposing the 
general community to resistant strains. 
 
1.5 Mechanism of Resistance 
 
Bacteria have developed various modes of resistance that seeks to keep antibiotics out of 
the cell such as selective permeability of the cell wall, porin channels and efflux pumps. 
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Or once antibiotics have entered the cell, neutralize them with various antibiotic 
modifying and target modifying enzymes.  
 
1.5.1 Porin Channels and Selective Impermeability 
 
The current model of mycobacterial cell wall has a cell envelope that is supported by a 
peptidoglycan sacculus and a cell wall containing two layers that includes a long chain 
lipophilic mycolic acid bilayer that is asymmetrical and helps in limiting the entry of 
hydrophilic molecules (Jarlier and Nikaido 1994). Wrapped underneath it is an 
arabinogalactan layer that prevents hydrophobic molecules from entering (Brennan and 
Nikaido 1995). Anchored to this is a waxy and non fluid mycolate barrier which allows it 
to limit the entry of both hydrophobic and hydrophilic compounds (Liu et al 1995). This 
structure is further reinforced by a trehalose dimycolates and glycopeptidolipids network, 
forming the exterior. Therefore, certain enzymes such as FbpA that are responsible for 
mycolic acid chain assembly and construction of the envelope are also responsible in 
conferring various degrees of resistance to a range of antibiotics (Nguyen et al 2005). 
 
1.5.2 Efflux Pumps 
 
The outer envelope of cell plays an important role in conferring antibiotic resistance to 
Mycobacteria, considerably slowing the rate of drug entry into the cell (Jarlier and 
Nikaido 1994). This rate of entry allows the cell enough time to activate resistance genes 
to either neutralize or export these compounds, including efflux transporter genes that can 
be found across the genome in M. tuberculosis. These genes encodes for 26 ATP binding 
cassettes (ABC) transporters and 16 major facilitator proteins (Braibant et al 2000; De 
Rossi et al 2002). Research has experimentally demonstrated that transporters confer 
resistance to a range of antibiotics, including fluoroquinolones, rifampicin, 
chloramphenicol, tetracycline and aminoglycosides (Nguyen and Thompson 2006). 
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1.5.3 Antibiotic Degrading and Target Modifying Enzymes 
 
Another form of resistance is the ability for the cell to degrade the small amounts of 
antibiotics that have penetrated through the cell wall. An example of this is the 
expression of β-lactamases, which degrades β-lactam antibiotics that undermines cell 
wall structure by inhibiting peptidoglycan assembly enzymes (Chambers et al 1995). This 
enzyme is encoded by the genes blaS and blaE in M. smegmatis and blaC in M. 
tuberculosis and is also produced under normal growth conditions (Flores et al 2005). 
Another strategy is to modify the target that antibiotic acts upon, causing the drug to have 
no effect on the cell. One example is erm37, which is found in the M. tuberculosis 
complex (MTC) and confer resistance to macrolide and lincosamide (Nguyen and 
Thompson 2006).  
 
1.5.4 Mimicking Drug Targets 
 
A new way of antibiotic resistance involves genes producing proteins that resemble an 
antibiotic target. An example of this is the gene mfpA, which encodes a protein that 
resembles a DNA double helix (Hegde et al 2005). This confers resistance to 
fluoroquinolones, which acts against mycobacteria by binding to the enzymes DNA 
gyrase and topoisomerase IV. This ensures that the DNA strands are not resealed, thus 
ensuring its eventual degradation which in turn will lead to cell death (Nguyen and 
Thompson 2006).  
 
1.5.5 Regulation of Resistance Mechanisms 
 
All intrinsic resistance mechanisms described above are controlled by a system that 
seems to have been retained in mycobacterium species and other bacterial species in the 
Actinomycete taxon (Morris et al 2005). In both antibiotic producing and pathogenic 
Actinomycetes (such as Streptomyces), a transcriptional regulator WhiB7 controls a set 
of resistance genes found in eight loci with four open reading frames (Philalay et al 2004) 
that are responsible in dealing with antibiotics that have entered the cytoplasm. A large 
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part of the resistance mechanism in mycobacteria is also controlled by a WhiB7 
homologue thought to also have evolved in the same natural environment (Nguyen and 
Thompson 2006). WhiB7 not only confers resistance to various antibiotics but also plays 
a role in the pathogenicity of mycobacteria, thereby ensuring its long term survival during 
the latency period  
 
1.6 Bacteriophage Mediated Antimicrobial Activity 
 
The ease of spread of TB, the lack of new drugs being introduced and frequent misuse or 
overuse of these drugs, combined with a comprehensive intrinsic resistance mechanism 
has resulted in the steady erosion of in the ability of antibiotics to act against TB. This, 
coupled with the rapid spread of HIV among developing nations, especially in sub-
Saharan Africa, and the mounting challenge in the development of new antiretroviral and 
antimicrobial drugs that are compatible with each other has called for new approaches in 
tackling the global TB problem.  
 
One solution lies in finding novel antimicrobial targets and the synthesis of new 
antimicrobial drugs to act against them. This solution focuses on the understanding the 
M. tuberculosis genome. With the advance in sequencing technology, the first bacterial 
species to have its genome completely sequenced was done on Haemophilus influenzae in 
1995 (Fleischmann et al 1995) paved the way for more of the same sequencing of other 
bacterial species and showed hundreds of genes that are vital for in vitro growth 
confirmed by mutagenesis experiments (Brown 2004). While these studies provide 
information on potential targets for developments of new antimicrobial drugs, it only 
serves to confirm their importance in maintaining cell vitality yet provides no new 
information as to their exact cellular function. To further understand functions of these 
potential targets and to prioritize them for drug discovery, one approach adopted by Lui 
et al in 2004 focused on the use of bacteriophages. 
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1.7 Phage Diversity 
 
Bacteriophages, especially lytic phages, are absolute parasites to bacteria. Therefore they 
have billions of years of evolutionary history with their host and thus have ensured that 
phages are not only abundant in numbers in the virosphere, but also the most abundant 
source of genetic diversity on the planet (Suttle 2007). This phenomenon is first observed 
from studies done on marine phages (Bergh et al 1989; Suttle et al 1990), where 
bacteriophages play an important role of nutrient recycling and also transfer genetic 
material between host species. Bacteriophages are also abundant in numbers, with an 
average of 10 million viruses per milliliter of sea water (Bergh et al 1989) with numbers 
for any given phages depends on the numbers of their corresponding hosts.  
 
Phage diversity was first observed when electron microscopy performed on marine 
phages which show that phages are morphologically diverse (Torella and Morita 1979). 
Other studies focused on the target genes (Wilson et al 1999, Frederickson et al 2003) 
revealed profound genotypes difference of various communities that were separated by a 
mere few meters, showing that marine phages consist of extremely diverse communities 
existing in close proximity to each other.  
 
These studies, however, cannot provide information about overall genetic diversity of 
phage communities because the target genes that are used are found only in phages that 
can be cultured. An approach to over come this involves using metagenomic studies, 
where phages are directly collected from water samples and sequenced through shotgun 
sequence techniques or Sanger sequencing techniques. One such metagenomic study 
(Breitbart et al 2002) examined two uncultured phage communities from costal areas. 
The results show that over 65% of sequenced genomes do not show any sequence 
similarity to those in the database. Of the sequences that show various degrees of 
similarities, only a third of these sequences had their closet match to known phage 
sequences. 
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Such diversity is apparent in the mosaic arrangement of phage genes in their genome, by 
which phage genomes consist of assemblies of various genetic modules. These modules 
can be a part of a gene, a whole gene or a group of genes and can be found in phages that 
are not related. This is observed not only in sequenced marine phages but also in cultured 
phages as well. In a review (Casjens 2005) that examined the diversity within 
Caudovirales shows that although various tailed phage groups that infect a common host 
(E. coli) share similar lifestyles, gene arrangements, number of genes and transcription 
patterns, they vary greatly in their sequence similarity. An example could be seen in the 
sequencing of some 20 phages that are related to the phage λ and yet are all related to one 
another only through their mosaic arrangement of genes. Two phages, P22 and N15, have 
a number of genes that are very similar to those in λ but have very little sequence 
similarities with themselves (Hendrix and Casjens 2005; Casjens 2003).  
 
1.8 Mosaicism 
 
There are two types of mosaicism: Quantitative and qualitative. The former is the 
recombination of sequences from homologous regions of phage genomes, thus creating a 
family of homologous genes through simple divergence. This can arise from genes that 
are recently diverged (and are almost identical to each other) to genes that share such a 
long divergent history that their similarities can no longer be recognized since they have 
diverged beyond such point. Qualitative (or modular) mosaicism results from the non-
homologous (illegitimate) recombination of genes that are either very divergent 
homologue or a non-homologue (also know as Not Recognizably Homologous genes – 
NRH). Hence when these phages are compared, it will result in patches of regions where 
sequence similarities between abruptly ends, resulting in regions know as novel sequence 
joints, with most of such joints found at gene boundaries. These illegitimate 
recombinations occur randomly with unnecessary genetic material deleted and nearby 
genes rearranged. Studies (Hendrix 2003; Pedulla et al 2003) have identified novel joint 
regions containing these genetic materials supporting this model of recombination. If the 
exchange of these modules occurred recently in its evolutionary time frame, then its 
sequence similarity will still be similar to each other. If the exchange occurred some time 
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ago in evolutionary time, then the only similarity would only show through from the two 
amino acid sequence being statistically significant.  
 
1.9 Diversity within Mycobacteriophages 
 
Mycobacteriophages also exhibit a high amount of mosaicism, indicating its high 
diversity. A study done by Hatful et al in 2010 analyzed 60 known mycobacteriophages 
sequences. Of the 60 sequences, 55 of them were grouped into nine clusters that share 
sequence similarities with the last 5 not fitting into any of the nine clusters. Of those nine 
clusters, five of them were able to be divided into sub-clusters with the phages within 
each clusters varied greatly in their sequence similarities to each other. An example of 
this is shown for 6 genomes within the Cluster D sharing on average 97.5% of sequence 
similarity while 2 genomes within Cluster I having similarities that were not apparent. In 
addition to comparing whole genomes, Open Reading Frames (ORFs) were also 
predicted for the 60 mycobacteriophages. A total of 6858 ORFs were predicted and 
grouped into clusters of related sequences called phamilies (phams). Close to half (46%) 
of these phams in a total of 1523 contains only a single ORF while 18.8% of the total 
phams have sequence similarity to other bacteriophages. Assigning functions to these 
ORFs remain a difficult as only 10% of all phams can be identified with a known 
function on the database. This clearly shows the great amount of variety with a small 
sample size (60) of mycobacteriophages and identifying this type of phage to be greatly 
diverse like all other phages communities so far encountered. 
 
1.10 Application of Bacteriophages as Antimicrobial Agents 
 
Given the ability of phages to not only destroy its host cell, but replicate exponentially. It 
has been used in various ways as an antimicrobial agent against a variety of infectious 
diseases. One such use is the Direct Phage Therapy. This was first pioneered by Felix 
d’Herelle in 1917 in which he successfully treated patients with intestinal dysentery after 
successfully isolating the first phage. But with the advent of antibiotics in the 1940s, 
phage therapy was largely abandoned in the West after World War II, but advances in the 
 10 
clinical application of phages was made many advances in the Soviet Union and the 
Eastern Bloc due to these states being cut off from Western medical technology with the 
advent of the Cold War. Many phage research and production facilities were set up in the 
USSR both before and after WWII. These facilities produced phages that can be applied 
in many different forms, from orally ingested liquids and tablets to locally applied creams 
(Chanishvilli 2009). Soviet phage research enjoyed a high degree of success (Kutateladze 
and Admia 2010), but their knowledge on phages were slow to diffuse to the West. 
 
With the growing threat of antibiotic resistance, however, phages now serves as a viable 
alternative as an antimicrobial agent. According to Kutateladze and Admia, when 
compared to antibiotics, phages offer several advantages:  
 
1) Since phages multiply naturally, contrasting to synthetic antibiotics, they can act 
as a self regulating drug. Unlike an antibiotic that needs to be constantly ingested 
at a regular interval (pill burden) due to clearance from the body, the number of 
phages will naturally decrease once all bacterial cells are eliminated. 
2) The restricted host range of phages means that it is only able to target specific 
bacterial species, unlike antibiotics that can eliminate a broad range of bacterial 
cells, even if they are beneficial. 
3) Phages do not have harmful side effects which is generally associated with wide 
spectrum antibiotics. 
4) Even if the bacteria show resistance to a single phage or a cocktail of them, the 
host must mutate or lose one or more of its receptors. This could lead to a 
reduction in the fitness of the cell which could help slow down the progression of 
disease. If the receptor is a virulence determinant, then bacterial virulence will 
decrease. 
 
Despite the need to find a new alternative to antibiotics, questions are still being raised 
about the feasibility of phage therap. Skurnik and Strauch (2006) argued that more 
information is needed on the fate of phages in humans and animals, and how these phages 
can perform in vivo and also the in vivo data of one phage in relations to another. The 
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latter is important if various phages are to be administered together as a cocktail. 
Furthermore, the functions of vast amount of phage genes are still unknown with 
sequence similarity to unknown genes from various organisms. Research has shown that 
certain phages carry virulent factors and toxin genes. Examples include phage conferring 
pathogenicity to Streptococcus pyogenes (Broudy and Fischetti 2003), and CTX cholera 
(Davis and Waldor 2003) and shiga toxin (Strauch et al 2004). Hence, no phage therapy 
should be attempted until the genome of any candidate phage is sequenced and its 
interaction with the host fully understood. 
 
1.11 Phage Products 
 
Besides direct phage therapy, another way of using bacteriophages as antimicrobials is to 
use phage produced enzymes, particularly lytic enzymes (lysins) which target the bonds 
of the peptidoglycan of the cell wall (Young 1992). Like the phages from which they are 
isolated and produced, most lysins can only target specific species of bacteria (Fischetti 
2005). This ensures that only the target pathogen will be lysed, leaving beneficial 
microorganisms within the human body untouched.  However, research has shown that 
lysins can also be broad spectrum and target multiple bacterial species. An example of 
this is the lysin isolated from enterococcal phages that are able to target Staphylococcus 
aureus, and S. pyogenes (Yoong et al 2004).  
 
So far, research has show that there is no case of reported resistance against lysins. One 
possible explanation is that because phages have co evolved with bacteria for millennia, it 
has developed strategies to prevent itself from getting trapped inside its host. By 
developing lysins that target essential molecules of the cell wall, it makes resistance 
against it very difficult (Fischetti 2005). This has the potential to make lysins the ideal 
candidate for an alternative to antibiotics but can also shed light on new bacterial targets 
for the development of new antimicrobial drugs. Lysin is but one of the many phage 
products that can act against bacteria.  
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1.12 Phage-Host Interactions 
 
Other studies have been conducted to determine the genetic and molecular mechanism by 
which bacteriophages increases its efficiency of infection of the host by interacting with 
host cells at a genetic level. The interactions at this level are focused on the inhibition, 
activation or redirection of host proteins to phage use and such interactions occurs at all 
stages of the infection cycle, encompassing host transcription, translation and replication.
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Table 1.2 Review of some bacteriophage-host interactions, unknown modification are left blank (adapted from Roucourt and Lavigne) 
Phage 
Phage 
protein Host protein Modification Effect Length Stage 
 
T7 gp0.3 Type 1 restriction endonuclease  Protection of genome from restriction 117 Early 
 
gp0.7 C-
term RNA Pol β' subunit  Host transcription shutoff 117 Early 
 
gp0.7 N-
term RNA Pol β and β' subunit Phosphorylation Efficiency of termination 242 Early 
  RNase III Phosphorylation Processing of T7 mRNA   
  RNase E and RhIB Phosphorylation Protection of T7 mRNA from degradation   
  
Translation, initiation and elongation 
factors Phosphorylation Unknown   
 gp2 RNA Pol β' subunit  Inhibition of transcription initiation 64 Middle 
 gp1.2 dGTPase  Inhibition of GTPase 85 Early 
       
T4 Alt One RNA Pol α subunit Ribosylation Preferential expression of T4 early genes 675 Late 
 Alc RNA Pol β' subunit  Host transcription shutoff 167 Early 
 ModA Both RNA Pol α subunit Ribosylation Lower expression of T4 early and host genes 200 Early 
 ModB 
S1 ribosomal protein, trigger factor, 
Ef-Tu Ribosylation Unknown 207 Early 
 AsiA σ70 factor  Inhibition recognition of σ70 promoters 90 Early 
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Phage 
Phage 
protein Host protein Modification Effect Length Stage 
 
 
MotA σ70 factor  Recognition of T4 middle promoters 211 Early 
 gp55 RNA Pol core enzyme  σ factor for expression from late promoters 185 Middle 
 gp33 RNA Pol core enzyme  Helper of gp55 112 Middle 
 RpbA RNA Pol core enzyme  Favours expression of T4 late genes 129 Early/Middle 
       
Twort gp168 DnaN (DNA Pol III β subunit)  Shutoff host replication 74 Unknown 
       
G1 gp240 DnaN (DNA Pol III β subunit)  Shutoff host replication 58 Unknown 
       
λ P DnaB (DNA helicase)  Initiation of λ genome replication 233 Delayed Early 
 N RNA Pol core, NusA, NusG  Antitermination, delay early transcription 133 Early 
 Q RNA Pol holoenzyme (core + σ70)  Antitermination, late transcription 207 Delayed early 
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However, most of these phage proteins identified do not show sequence similarities to 
other known proteins and hence very little is known about their exact functional 
mechanism. Even within the well known and studied phage T4, about half of predicted 
ORFs do not have a known function, and majority of these ORFs are transcribed by early 
promoters (Miller 2003). But since some early phage proteins clearly exhibit antimicrobial 
properties, most research focus have shifted to using such proteins to identify new 
antimicrobial targets (Liu 2004) while ignoring other non inhibitory proteins, making most 
phage-host interactions remained unstudied. 
 
1.12.1 Interaction in Host Defence and Patterns of Phage-Host Co-Evolution 
 
One advantage of using bacteriophages as antimicrobial agents is the ability of phages to 
co-evolve with their bacterial host in order to overcome host defence mechanism against 
viral infections (Tock and Dryden 2005). The bacterial restriction-modification system 
contains two enzymatic functions that allow the host to protect itself against the entry of 
foreign DNA (such as those of phages). One function employs restriction endonuclease 
(RE) to recognize and cleave a specific DNA sequence with the other employing a 
methyltransferase that will modify host DNA by means of host methylation of adenine or 
cytosine bases. This ensures that the foreign DNA will be destroyed through cleavage by 
RE while the host DNA will be protected through modification of bases within the 
recognition sequence (Boyer 1971, Yuan 1981). However, with the co-evolution between 
bacteriophages and their hosts, phages have developed several strategies to overcome such 
defence, they include: Inhibition of RE (Tock and Dreyden 2005); degradation of enzyme 
cofactors; methylation of phage DNA; sequence alteration; and incorporation of 
hypermodified bases in phage DNA (Warren 1980). 
 
1.13 Phage Mediated Target Identification 
 
The interactions discussed above shows that bacteriophages employ sophisticated 
mechanisms to influence host replication machinery and metabolism. Given that most 
phages are extremely diverse and share very little sequence similarities with each other, 
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characterization of function for phage proteins remains difficult. However, although limited 
in understanding of the functionality of phage proteins and their interactions, several 
studies are now providing new information about some of the interactions discussed above. 
This allowed Roucourt and Lavigne (2009) to propose several hypotheses that are 
applicable to early phage proteins: 
 
1) Known interactions are not isolated events but rather very common with bacterial 
and archeal viruses and are directed by early proteins. 
2) Most interactions are not essential to infection, although they increase efficiency of 
infection. 
3) Of these non-essential proteins, only a small fraction of these proteins are needed 
for efficient infection in very specific conditions 
4) It is likely that any interaction between any given phage and its host is dependent on 
the proteins that are encoded by that particular phage or more specifically, what is 
not encoded by the phage. This mean phages that lack certain mechanisms or 
metabolic functions will encode proteins that will redirect that particular 
mechanism/function to increase its efficiency in the infection cycle. 
 
Although most understanding of phage proteins and their specific individual functions 
remain limited, recent studies into whole genomes of bacteria has provided many in depth 
information on bacterial genes and the importance of certain bacterial genes to the 
functioning of the cell. Through many mutagenesis studies in various bacteria, results 
suggest a wide range of genes are needed by the cell for growth and much more for 
pathogenesis (Mecsas 2002). This provides a wide range of potential targets for synthesis 
of new antimicrobial drugs. However, these studies do not provide information of their 
functions, but only whether a given gene is essential to viability or pathogenesis. Since 
phage strategies consist of encoding its own proteins to interact with that of the host with 
the aim of increasing infection efficiency and eventual destruction of the host cell, 
continuous studies into phage proteins will provide insights into phage tactics developed 
over billion of years of evolution relationship between viruses and hosts and also specific 
functions of host genes. Hence, the results shown in these investigations into the 
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functionalities of bacteriophage proteins will not only have importance in phage biology, 
but will also have practical applications from phage therapy to more direct applications 
such as identifying new targets for the development of novel antimicrobial drugs that can 
produce similar effects to phage proteins 
 
A study done by Liu et al in 2004 first used this approach to first discover antimicrobial 
targets before prioritizing them for drug discovery. This study focused on the pathogenic 
bacterium Staphylococcus aureus and their associated phages. A sample of 26 lytic S. 
aureus phages was sequenced and the genome analyzed through controlled expression of 
phage open reading frames (ORFs). Phage products that display inhibitory characteristics 
were selected for and these 26 phages produced 895 ORFs which yield 31 different 
families of inhibitory proteins. These proteins were then analyzed through affinity 
chromatography whereby host proteins were isolated when passed through an affinity 
matrix of phage inhibitory proteins. Identification of these proteins was then done through 
mass spectrometry, and 7 phage proteins, with size ranging from 25 to 297 amino acids 
were derived from such analysis. Their targets include proteins from some of the host 
transcription and translational machinery mentioned in Table 1.2, such as β-subunits of 
DNA polymerase III and helicase loader. These replication enzymes were confirmed to be 
indispensible to the cell when their chromosomal copies were deleted and through 
conditional rescue with plasmids containing these copies expressed through an IPTG 
inducible promoter. Since none of these host proteins in the replication machinery are 
currently being targeted by antibiotics (with the exception of DNA topoisomerase), the 
identification method employed by Liu et al can help extensively expand the list of 
essential host targets that can be exploited as new antimicrobial drugs are synthesized. 
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1.14 Aim of the Study 
 
The aim of this study is to identify novel mycobacteriophages and their phage products 
which are inhibitory to Mycobacterium smegmatis. Phages will be isolated from various 
soil samples and then characterized. Genomic libraries will be built using shuttle vectors 
transformed into E. coli and individual clones obtained. These clones will then be 
transformed into Rhodococcus erythropolis to screen for antimicrobial properties. Clones 
that exhibit these properties will be sequenced and their similarities examined against those 
in the database. Whenever possible, minimum necessary DNA will also be determined on 
these clones. Chosen clones will also be transformed into Saccharomyces cerevisiae to see 
whether they exhibit antimicrobial properties in eukaryotes.  
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2. Material and Methods 
 
2.1 Bacterial and Phage Strains used and Growth Conditions 
 
All bacterial sstrains used were sourced from Sibayama 2006 and Sibayama 2011. All 
phage strains used in this study are isolated from soil samples mentioned in this work. 
Exception is the rifampicin and streptomycin double resistant mutant of M. smegmatis, 
which was generated from non resistant M. smegmatis MC
2155 and grown in 100μg/ml of 
rifampicin and streptomycin. Bacterial strains used in this work are listed in the table below 
and phages used throughout this work is listed in Table 2.2 
 
Table 2.1 Bacterial strains used in this study 
 
 
N. aobensis IFM 10795 
N. nova IFM 10797 
N. brasiliensis IFM 10745 
N. farcinica IFM 10757 
N. farcinica IFM 10779 
M. parafortuitum 490 
M. smegmatis MC
2
 155 
G. rubropertincta ATC25593 
R. erythropolis 4277 
R. rhodochrous 01 
R. equi 
R. erythropolis SQ1 
E. coli MM294-4 
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Table 2.2 Phages used in this work. Nomenclature of phages was based on the location 
from where their respective soil samples originates. In the case of the “Botswana” phages, 
four phages were isolated from two soil samples collected from Botswana, with “Botswana 
1” collected from Gaborone and “Botswana 2” from soil samples collected from Mochudi  
 
 
 
 
 
 
 
 
 
 
All bacterial liquid cultures were grown in Luria Broth (LB) medium agitated on a shaker 
or a wheel and all plate cultures are grown on solid LB medium with 1.5% agar (LA).  
 
For bacterial growth conditions, E. coli MM264-4 was grown in 37
o
C overnight 
supplemented with 100μg/ml nalidixic acid. M. smegmatis MC2155 was grown in 37oC for 
two days supplemented with 100μg/ml rifampicin while double resistant mutant used for 
transduction was grown with 100μg/ml rifampicin and streptomycin. For R. erythropolis 
SQ1, culture was supplemented with 50μg/ml of rifampicin. All other bacterial strains were 
grown in 30
o
C for 2 – 4 days. All bacterial cultures were stored at 4oC and for long term 
storage; cultures were stored in -70
o
C in 33% glycerol. 
 
Liquid S. cerevisiae culture was grown in YPD medium at 30
o
C agitated on a shaker.  
All phages were propagated with M. smegmatis MC
2
155. For transduction, phages were 
propagated with its rifampicin and streptomycin double resistant mutant. All phage 
suspensions were stored at 4
o
C.  
 
All media, reagents and their composition can be found in Appendix A.  
Mozambique 1 
Mozambique 3 
Caltech 1 
Caltech 3 
Botswana 1 A 
Botswana 1 B 
Botswana 2 A 
Botswana 2 B 
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2.2 Plasmids 
 
All plasmids used throughout this work are listed in the table below 
 
Table 2.3 Plasmids used in throughout this work 
Plasmid Characteristics Source 
pDA71 E. coli - Rhodococcus shuttle vector; Amp-R Y. Shibayama 2006, 2011 
pUC 18/19 E. coli cloning vector; LacZ'; Amp-R Fermentas 
pSHLeu S. cerevisiae cloning vector; Kan-R; Leu 
M. Kitakawa (X. Gan et al 
2002) 
 
In E. coli, transformants for both pUC18/19 and pDA71 was selected with 100μg/ml 
ampicillin and in R. erythropolis; 40μg/ml was used in the selection for transformants. For 
pSHLeu, 100μg/ml kanamycin was used to select for transformants in E. coli, while for S. 
cerevisiae. Plasmids were stored in 6M CsCl. 
 
2.3 Isolation and Propagation of Mycobacteriophages 
 
2.3.1 Soil Assay 
One gram of soil sample in 10ml LB supplemented with 10mM of CaCl2 and 10mM MgCl2 
(thereafter referred to as divalent ions and for all subsequent supplementation of both these 
ions the concentration remains 10mM) was agitated on a shaker for 16hrs in 37
o
C at 90 – 
100 rpm. This soil suspension was then centrifuged in a Beckman JA-20 rotor at 15000 
rpm for 10min. 2ml of supernatant was added to 30μl of M. smegmatis stationary culture in 
1ml of LB in a test tube. This mixture was then briefly vortexed for 1sec and then 
incubated at 37
o
C for 30min. 3ml of sloppy agar was then added to this mixture, mixed by 
rolling the test tube between the palms and poured onto a LA plate supplemented with 
100μg/ml rifampicin and 50μg/ml nystatin, and divalent ions. The overlaid plate was then 
incubated at 37
o
C for 2 days and observed for plaques. 
 
2.3.2 Production of Phage Suspension and Single Plaque Purification 
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A single plaque was picked with a sterile toothpick piecing through the sloppy agar and 
mixed into 100μl of dH2O. This was then briefly vortexed, left to stand on bench for 10min 
and microfuged for 2min. The phage containing supernatant was then serially diluted to 
determine the titre of the phage suspension and also the dilution required to produce single 
plaques. 10μl of the diluted phage was mixed with 30μl of M. smegmatis stationary phase 
culture in 2ml LB in a test tube, vortexed briefly and incubated for 30 min at 37
o
C. 2ml of 
sloppy agar was added and mixed by rolling test tube between the palms and poured onto 
an agar plate supplemented with divalent ions. The overlaid plate was incubated for two 
days at 37
o
C. 
 
2.4 Phage Characterization 
 
2.4.1 Calculating Plaque Forming Unit (pfu) 
 
An LA plate, supplemented with divalent ions was first overlaid with M. smegmatis and 
dried with lid open at 40
o
C for 20min. A serial dilution (to 10
-7
) of the phage was then 
prepared with dH2O and10μl of each dilution was spotted onto the plate, incubated for 2 
days at 37
o
C or until plaques are visible. The following formula was used to calculate 
pfu/ml: 
 
pfu/ml = number of plaques × dilution factor 
  volume 
 
 
 
2.4.2 Calculating Colony Forming Unit (cfu) 
 
M. smegmatis culture was serially diluted to 10
-7
 with dH2O and 100μl of the dilutions 10
-4
 
– 10-7 was each spread across an LA plate, incubated at 37oC for 2 days or until colonies 
were visible. The following formula was used to calculate cfu/ml: 
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cfu/ml = number of colonies × dilution factor 
    volume 
 
2.4.3 Divalent Ion Requirements 
 
Four LA plates: One supplemented with divalent ions; two plates, one supplemented with 
10mM MgCl2 only and another with 10mM of CaCl2 only; and one with no ions added 
were prepared. Onto each plate was overlaid 20μl of stationary phase M. smegmatis and 
dried with lid open at 40
oC for 20min. Onto each plate, 10μl of phage suspension was 
spotted onto the plate and incubated at 37
o
C for 2 days or until plaques were visible. 
 
2.4.4 Host Range Test 
 
Test strain was overlaid onto an LA plate supplemented with divalent ions and dried with 
lid open at 40
oC for 20min. 10μl of phage suspension was spotted onto the plate and 
incubated for 2 days and observed for plaques. 
 
2.4.5 Transduction 
 
Rifampicin and streptomycin double mutant prepared by spreading 300μl of rifampicin 
resistant M. smegmatis stationary culture on an LA plate supplemented with 100μg/ml 
rifampicin and streptomycin and incubated for 2 days or until colonies were observed. A 
single colony was picked with a toothpick and grown in liquid culture supplemented with 
100μg/ml rifampicin and streptomycin. This liquid culture is then used for the production 
of phage plate lysates. Lysates was prepared, collected and titrated.  
Phages and cells were mixed together to achieve two MOIs of 0.1 and 1.0 and made to a 
final volume of 300μl supplemented with divalent ions. Tube was inverted to mix and left 
to stand in room temperature for 30min. Cells were collected by microfuging for 5min and 
pellet was washed once with dH2O before being resuspended in 500μl of LB and spread on 
a LA plate supplemented with 100μg/ml rifampicin and streptomycin. Plate was incubated 
for 14 days and observed every 2 days for formation of colonies. 
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2.5 Lysate Production 
 
2.5.1 Plate Lysate Production 
 
A serial dilution of 10
-1
 and 10
-2
 of the phage suspension was made and 10μl of this 
dilution was added to 30μl of M. smegmatis in 2ml of LB and incubated for 30min at 37oC. 
2ml of sloppy agar was added to the plate lysate, mixed by rolling between the palms and 
poured onto a LA plate supplemented with divalent ions. Plates were incubated for 2 days 
at 37
o
C or until there is a significant difference between the plate lysate and that of the cell 
only control. 
 
Onto the plate lysate, 2ml of LB was added and using a spatula, all liquids and sloppy agar 
was gathered into a centrifuge tube. This was briefly vortexed, left for 10min and 
centrifuged for 10min at 15000 rpm with a JA-20 rotor. Supernatant was kept and titrated 
to determine whether the plate lysate has the desired titre of ≤109 pfu/ml.  
 
2.5.2 Production of Small Scale Liquid Lysate 
 
Into three 100ml flasks, 200μl of stationary phase M. smegmatis culture was added 9.8ml 
of LB supplemented with divalent ions to make up total volume of 10ml and mixed by 
gentle swirling. Into the first flask, 100μl of plate lysate was added, mixed by gentle 
swirling and from the first flask, 100μl of this mixture was transferred to the second flask. 
This was repeated from the second flask to the third. All three flasks were incubated for 16 
– 18 hrs at 37oC agitated at 100rpm at a rotary shaker. Flasks were then collected and 
contents centrifuged at 15000 rpm for 10min with a JA-20 rotor. Supernatant was kept and 
titrated to determine whether the lysate has achieved titre of ≤ 109 pfu/ml. Other MOIs and 
conditions were also tested. 
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2.5.3 Production of Large Scale Liquid Lysate 
 
Conditions and MOIs used in the production of small scale lysates was applied in the 
production of 500ml large scale liquid lysate (5 × 100ml in 5000 ml flask). 
 
2.6 Phage Purification in an Equilibrium Gradient 
 
Into the large scale lysate, NaCl and polyethylene glycol (PEG) 6000 was added to a final 
concentration of 1M and 10% (w/v) respectively. Both are dissolved by the slow stirring of 
a magnetic stirrer. The lysate was then cooled in a ice slurry for 1 – 1.5hrs and centrifuged 
at 4
o
C at 9000rpm for 20min. Supernatant was discarded and pellet resuspended in 5ml of 
SC buffer containing 81.7% (w/v) CsCl and loaded into a Beckman Quick-Seal centrifuge 
tube and centrifuged at 38000rpm at 4
o
C for 24hrs. A blue purple band was observed and 
was extracted with a needle and syringe and titrated. 
 
2.7 Transmission Electron Microscopy 
 
2.7.1 Preparation of Formvar-Carbon Coated Copper Grids 
 
A microscope slide was dipped vertically into 0.50% Formvar solution until half to three 
quarters submerged. Slide is removed and dried by left standing vertically for 2 – 3 min and 
blotted on paper towel. A scalpel was used to scrape off the Formvar on the sides and 
corners of the slides and was dipped slowly into a tub of dH2O at a 45
o
 angle until a 
transparent film of Formvar was seen floating on the surface. Hexagonal 200-mesh copper 
grids were placed on the Formvar surface with the dull side of the grid facing downwards 
by means of fine forceps. The entire Formvar surface, with grids attached, was lifted onto a 
filter paper and air-dried on bench. The grids were then taken to be carbon coated by the 
Electron Microscopy Unit of the University of the Witwatersrand. 
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2.7.2 Negative Staining of Phages 
 
Both purified phages and phages from lysates were negatively stained. For purified phages, 
it was diluted to 10
10
 pfu/ml while that of lysates were not diluted. 5μl of phage suspension 
was placed on the Formvar-carbon coated side of the grid and left to stand for 30min. 
Excess liquid was then drawn off with a paper towel and 5μl of dH2O was placed on the 
grid and immediately drawn off with a paper towel. 5μl of 1% uranyl acetate was placed on 
the grid, left to stain for 20sec before being drawn off with paper towel. Grids were left to 
stand for 10 – 15min to be air-dried. 
 
2.7.3 Viewing of Negative Stained Phages 
 
Negatively stained phages was viewed and photographed with a Joel JEM-100S 
transmission electron microscope at 80 kV. Micrographs were developed by the Electron 
Microscopy Unit of the University of the Witwatersrand. 
 
2.8 Phage Genomic DNA Preparation 
 
2.8.1 Dialysis of Purified Phages 
 
Dialysis tubing of 5cm was boiled in 500ml of 2% NaHCO3 and 1mM EDTA (pH 8) for 
10min and rinsed in dH2O. Tubing was then boiled in 500ml of 1mM EDTA (pH 8) for 10 
min and rinsed in dH2O. 500μl of purified phage suspension was pipetted into the tubing 
and dialyzed in 500ml of dialysis buffer of 10 mM NaCl, 50 mM Tris-HCl (pH 8.0), and 10 
mM CaCl2 for 1hr while gently stirring with a magnetic stirrer. This was repeated again for 
another hour. 
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2.8.2 Phage Genomic DNA Extraction 
 
EDTA (pH 8), proteinase K, and SDS was added to the dialyzed phage suspension in a 
concentration of 20mM, 50μg/ml and 0.5% (w/v) respectively. This mixture was briefly 
vortexed and incubated at 56
o
C for 1hr and cooled in room temperature. Three phenol 
extraction and one chloroform extraction was preformed on the suspension and genomic 
DNA precipitated using salt-ethanol precipitation, and resuspended in dH2O. 
 
2.8.3 E. coli Mini Plasmid Preparation 
 
Single plasmid containing colony was inoculated in 1ml of LB supplemented with 100μl 
ampicillin and grown on a shaker for < 6hrs – overnight. Cells were pelleted by 
microfuging for 30sec and the supernatant decanted. 80μl of solution I was used to 
resuspend the cells and 160μl of solution II was added and mixed by slowly inverting 
several times and left to stand in room temperature for 10min. 120μl of solution III was 
added and mixed by shaking vigorously before being left to stand on ice for 5min. The 
mixture was then microfuged for 5min at 4
o
C and the supernatant was kept in a new 
microfuge tube and warmed at 42
o
C for 3 – 5 min. 220μl of isopropanol was added, 
inverted to mix and stood at room temperature for 5min. Plasmids was pelleted by 
microfuging for 5min and the pellet washed with 150μl of ethanol before being pelleted 
again by microfuging for 1.5min. Pellet was vacuum desiccated for 20min and plasmid 
DNA resuspended in 40μl of dH2O with 10μg/ml of RNase. 
 
2.9 DNA Manipulation 
 
2.9.1 Phenol-Chloroform Extraction 
 
TE buffer was added to a final volume of 300μl for any DNA suspension below this 
volume. 100μl of phenol was added, mixed by inversion and microfuged at 4oC for 10min, 
and the top layer (aqueous phase) was collected. One-third volume of chloroform was 
added to the collected solution, mixed by inversion and microfuged at room temperature 
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for 1min. The aqueous phase was again collected and subjected to salt-ethanol 
precipitation. 
 
2.9.2 Salt Ethanol Precipitation  
 
One tenth volume of 1M NaCl and two volumes of 96% ethanol were added to the DNA 
suspension and kept in ice for 30min. DNA was then pelleted by microfuging at 4
o
C for 
20min and vacuum desiccated for 20min. Pellet was resuspended in 100μl, or an 
appropriate volume of dH2O. 
 
2.9.3 Restriction Endonuclease Digest 
 
Restriction endonuclease was obtained from various commercial suppliers such as 
Fermentas, Roche or New England Biolabs and each used according to their instructions. 
For single digestions, 10× digestion buffer to the DNA suspension, along with the 
appropriate amount of endonuclease, mixed by lightly tapping the microfuge tube and 
briefly microfuged. For double digestions, a common buffer which allows for performance 
of both endonucleases was chosen and half volume of each of the two enzymes was added, 
mixed and microfuged. All digestions were incubated at the instructed temperature of ≤ 
2hrs.  
 
Enzymatic activities were stopped by heat treatment according to instructions and 
conditions provided. If heat inactivation is not a viable option, then phenol-chloroform 
extraction was performed.  
 
2.9.4 Dephosphorylation of Nucleic Acids 
 
To prevent recircularization of the plasmid, Fermentas alkaline phosphatase was used. 
Appropriate amount of 10× phosphatase buffer and alkaline phosphatase was added and 
incubated for 10min at 37
o
C. Enzymatic activity was then heat inactivated by incubating 
for 5min at 75
o
C. 
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2.9.5 Ligation 
 
Appropriate ratio of insert DNA and plasmid was added to a final volume of 17μl with 
dH2O. 2μl of 10× ligase buffer was added along with 1μl of Fermentas ligase, tapped to 
mix, briefly microfuged and incubated overnight at 22
o
C. Ligase was heat inactivated at 
65
o
C for 10min. 
 
2.9.6 DNA Agarose Gel Extraction 
 
Location of the DNA of interest was determined by examining agarose gel under UV light 
and excised using a scalpel. Excised piece was crushed using a spatula, frozen at -70
o
C for 
2hrs, thawed at room temperature and microfuged for 20min. Supernatant was kept. Tris 
was added to the supernatant to a final concentration of 50mM and subjected to two rounds 
of phenol extraction and one round of chloroform extraction. DNA was then precipitated 
using salt-ethanol precipitation and resuspended in 50μl of dH2O.  
 
2.9.7 Determining DNA Concentration 
 
5μl of DNA sample was ran on a gel, viewed and quantified using Bio-Rad Quantity One 
software. DNA was quantified by comparing the known quantity of band in molecular 
weight marker, express in its intensity, and comparing it to the intensity of the band of the 
sample. 
 
2.10 Gel Electrophoresis  
 
2.10.1 Agarose Gel Electrophoresis 
 
Agarose gels were prepared with concentration from 0.6% - 1.0% agarose depending on the 
size of DNA fragments that were separated. Appropriate amount of agarose was added to 
40ml of 0.5× TBE buffer and dissolved by heating. Ethidium Bromide (EtBr) to added to 
the agarose solution to a final concentration of 1μg/ml and poured into a comb inserted gel 
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tray at 4
o
C and polymerized for 20min. Comb was removed and gel tray placed into an 
electrophoresis unit containing 1μg/ml EtBr. DNA samples was mixed with 1 - 2μl of 
bromophenol blue tracking dye and electrophoresis was ran at 80 – 100V in room 
temperature. Gels were viewed and photographed using the Bio-Rad Molecular Imager Gel 
Doc XR System. Fermentas GeneRuler DNA ladder was used. 
 
 
2.10.2 Pulse Field Gel Electrophoresis (PFGE) 
 
A 1% agarose gel was prepared by dissolving agarose in 100ml of 0.5× TBE through 
heating and poured into poured into a PFGE gel tray and polymerized for 30min at 4
o
C. 
The New England Biolabs PFG Low Range marker, embedded in agarose, was cut to a 
length of 1mm and placed inside a well, with remaining spaces sealed with 1% agarose in 
0.5× TBE buffer and be allowed to be polymerized at room temperature for 10min. The gel 
was then placed in the electrophoresis unit, which was the BioRad CHEF-DR II Pulsed 
Field Electrophoresis System, which contains 2000ml of 0.5× TBE. DNA samples were 
mixed with 1 - 2μl of bromophenol blue tracking dye and loaded into the wells. 
Electrophoresis was conducted with initial and final switch times of 1 and 12sec 
respectively and at 6V/cm for 18.5hrs at 4
o
C. The circular pump was switched on after 
15min and ran at a circulatory rate of 750ml/min. Gel was then stained in 1μg/ml EtBr and 
viewed. 
 
2.11 Transformation 
 
2.11.1 E. coli Calcium Chloride Transformation 
 
An overnight E. coli pre-culture was inoculated into 20ml of LB supplemented with 0.5% 
glucose for at 37
o
C for 1.75hrs with vigorous agitation on a shaker. The new culture was 
cooled in a ice slurry for 5min whilst shaking, before being centrifuged in a pre-cooled 
JA20 rotor at 10000rpm for 10min. Supernatant was decanted and cells resuspended in 
10ml CaCl2 transformation buffer and placed in ice for 15min before being centrifuged at 
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10000rpm for 10min. Supernatant was again decanted and cells resuspended in 1.33ml of 
CaCl2 transformation buffer and placed in ice for 2hrs.  
 
20μl of plasmid suspension was added to 100μl of competent cells and mixed by bubbling 
before left to stand on ice for 15min. Cells were heat shocked at 42
o
C for 90sec and 0.5ml 
of pre-warmed LB added and incubated at 37
o
C for 1hr. Cells were spread on an LA plate 
supplemented with 100μg/ml ampicillin and incubated overnight at 37oC. For vector 
pSHLeu, LA plate was supplemented with 100μg/ml kanamycin. 
 
2.11.2 Rhodococcus PEG Mediated Transformation 
 
A R. erythropolis culture was grown in 5ml of LBSG (2% glycine) for 2 days in room 
temperature. 1ml of cells was then washed in B buffer, microfuged, resuspended again in 
1ml of B buffer containing 5mg lysozyme and incubated at 37
o
C for 1.5hrs with inversions 
every 10min. During the last 20min of incubation, 2ml P buffer was prepared and P-PEG 
buffer was made by preparing 0.5g of PEG6000 was UV-sterilized and dissolved in 1ml of 
P buffer. 
 
Cells was microfuged for 2min, washed once with 1ml B buffer, microfuged again, and 
resuspended in 500ml P buffer. 5μl of plasmid was mixed with 25μl of cell protoplast by 
bubbling and left to stand in room temperature for 10min. 30μl of P-PEG buffer was added, 
mixed by bubbling, spread onto a regeneration media and incubated at 30
o
C for 12hrs. 
After which the plate was underlay with 250μl of 4μg/ml chloramphenicol, and further 
incubated for 7 days or until colonies appear. 
 
2.11.3 S. cerevisiae Lithium Acetate Transformation 
 
1.5ml of YPD medium was inoculated with 30μl of an overnight culture of S. cerevisiae 
and incubated at 30
o
C for 4hrs or until the culture reaches to a concentration of ~2×10
7
 
cfu/ml. Cells was microfuged, washed once with dH2O, resuspended in 250μl of 100mM 
lithium acetate (LiAc) and incubated at 30
o
C for 10min. Cells was then pelleted, 
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supernatant decanted and reagents were added in the following order: 1) 25μl dH2O; 2) 
18μl 1.0M LiAc; 3) 12.5μl 2mg/ml SS-DNA; 4) 2μg plasmid; 5) 120μl 50% (w/v) filter 
sterilized PEG4000. Cell pellet was resuspended, reagents mixed by vigorous vortexing for 
2min and incubated at 30
o
C for 30min. Cells was then heat shocked at 42
o
C for 15min, 
collected by microfuging for 5min, resuspended in 0.5ml of dH2O, spread onto an SC plate 
and incubated in 30
o
C for 2 days. 
2.12 DNA Sequencing and Analysis  
 
All DNA sequencing reactions were done by Inqaba Biotech. All sequencing DNA was 
prepared through E. coli mini plasmid preparation with a phenol extraction preformed prior 
to isopropanol precipitation. Sequenced DNA were analysed and edited using the following 
internet programs  
 
Table 2.4 Internet programs used for sequence analysis  
Program Website Address 
BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi 
FASTA http://www.ebi.ac.uk/Tools/sss/fasta/ 
Softberry http://linux1.softberry.com/berry.phtml 
GeneMark http://exon.gatech.edu/ 
NEB cutter V 2.0 http://tools.neb.com/NEBcutter2/ 
 
2.13 Determining Phage Novelty 
 
Phages used in this study had their respective genome extracted, fragmented, cloned into E. 
coli and sequenced by Iqaba Biotech. These sequenced fragments were then compared with 
those in the data base for any similarities using BLAST. Although some phages used in this 
study do have high similarities with phages in the database, they are regarded as novel in 
the sense that these phages do not share exact identity with those in the database. These 
BLAST results were not included since it would lengthen the dissertation considerably.  
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3. Results and Discussions 
 
3.1 Isolation and Characterization of Mycobacteriophages  
 
3.1.1 Isolation of Mycobacteriophages from Soil 
 
To isolate mycobacteriophages, 1g of soil sample was agitated for 16hrs at 37
o
C, after 
which the samples was centrifuged. The supernatant collected was then mixed with M. 
smegmatis MC
2
155 and overlaid on a LCM plate. M. smegmatis was used since it is both a 
fast growing and a non-pathogenic species within Mycobacterium. This allowed for all 
isolation and any subsequent characterization of phages to be carried out in a safe condition 
in the shortest possible time. Four soil samples were collected and plaque yields are tabled 
below. 
 
Table 3.1 Soil samples and their respective phage yields 
Soil sample Plaques 
Bilene, Mozambique 70 
California Institute of Technology, California, United States 220 
Gaborone, Botswana (Botswana1) 20 
Mochudi, Botswana (Botswana 2) 8 
 
 
Figure 3.1 Phage assayed from Caltech soil 
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Plaques observed varied in sizes and were picked using sterile toothpicks and re-suspended 
in 100μl of water. Phage suspensions were spotted on LCM plates overlaid with M. 
smegmatis to start single plaque purification. This was repeated three times to ensure the 
purity of the phage. A total of 8 phages from the above 4 soil samples were selected and 
purified. 
 
3.1.2 Divalent Ion Requirement 
 
Selected phages were spotted onto a lawn of M. smegmatis overlaid on LA plates 
supplemented with both divalent ions, either one of the ions or none at all. These tests 
whether these phages can plaque without the divalent ions calcium and magnesium. These 
procedures were repeated three times to ensure that these phages, which were isolated 
using divalent ions, did not carry through the ions in this experiment. 
 
Table 3.2 The divalent ion requirement of selected phages 
 
3.1.3 Host Range 
 
Isolated phages were spotted onto a lawn of 10 different bacterial species and incubated for 
24hrs at 30/37
o
C depending on the host. A table of host species used is provided below 
 
Phage Divalent ion requirements 
Mozambique 1 None 
Mozambique 3 None 
Caltech 1 None 
Caltech 5 None 
Botswana 1A None 
Botswana 1B None 
Botswana 2A Calcium 
Botswana 2B Calcium 
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Table 3.3 Bacterial species used in testing host range 
N. aobensis IFM 10795 M. parafortuitum 490 
N. nova IFM 10797 G. rubropertincta ATC25593 
N. brasiliensis IFM 10745 R. erythropolis 4277 
N. farcinica IFM 10757 R. rhodochrous 01 
N. farcinica IFM 10779 R. equi 
 
Phages Mozambique 1, Mozambique 3 and Botswana 1A each showed slight clearing on 
one of the 10 bacterial species tested. Mozambique 1 showed clearing on N. brasiliensis 
and Mozambique 3 and Botswana 1A showed clearing on N. nova and N. aobensis 
respectively. The rest of the phages showed no visible signs of plaquing or clearing.  
 
Although none of the phages shows clear plaquing on the host strains tested, only one 
Mycobacterium species was tested. Research (Rybniker et al 2006) has show that different 
mycobacteriophages have different host range. These vary from broad activity of phage 
D29, which can infect both M. smegmatis and M. tuberculosis, to phage Barnyard, which 
can only infect a single known host. Some mycobacteriophage will even differentiate 
between strains of the same species.  
 
Although many aspects of these infection barriers are not known, it is presumed that 
specific host cell receptors are strong factors in host preferences of mycobacteriophages, 
although other cellular factors such as restriction and other metabolic requirements after 
phage DNA injection also play a role. Mycobacteriophages such as D4 have shown to be 
inhibited by lipid extracts of M. smegmatis (Tokunaga et al 1970) while other molecules 
such as methylated rhamnose residues associated with M. smegmatis cell wall have been 
show to be involved with the infection of phage I3 (Chen et al 2009). 
 
. 
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3.2 Production of Phage Lysates and Phage Purification 
 
For the extraction of phage DNA, observation of phage morphology with TEM and to 
perform transduction, it was necessary to produce a large volume of phage lysate that is 
high in titre. The plate lysate first produced yielded a titre with an average of 10
6 
in 5mls 
and was subsequently used in the production of liquid lysate of 10ml which yielded a titre 
with an average of 10
9
. Thereafter, liquid lysates were up scaled to 500ml in preparation of 
precipitating these phages for DNA extraction. 
 
3.2.1 Plate Lysate 
 
These were produced by incubating M. smegmatis with phage for 30 minutes at 37
o
C in 
liquid medium before overlaying it on LCM agar plates and incubating them again at 37
o
C 
for 48hrs. The amount of bacteria used for each case was 9 ×10
6
. The exact concentrations  
of both phages used and titres are provided below. 
 
Table 3.4 Titres used in the production of plate lysates and subsequent titres  
 
 
 
 
 
Phage Initial titre (pfu) ×10
4
 MOI Final titre (pfu/ml) ×10
8
 
Mozambique 1 20
 
0.02 20
 
Mozambique 3 10
 
0.01 9
 
Caltech 1 8
 
0.009 40
 
Caltech 5 30
 
0.03 70
 
Botswana 1A 40
 
0.04 70
 
Botswana 1B 30
 
0.03 80
 
Botswana 2A 6
 
0.006 300
 
Botswana 2B 7
 
0.007 80
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3.2.2 Liquid Lysates 
 
Liquid lysates were produced by incubating M. smegmatis with phage in a 10ml broth 
supplemented with divalent ions calcium and magnesium and agitated on a shaker for 16hrs 
at 37
o
C. Below are the concentration of both bacteria and phage.  
 
Table 3.5 Amount of phage and bacteria used in the production of small scale liquid 
lysates and final titres 
 
The small scale liquid lysate was in turn used in the production of large scale liquid lysate 
of 500ml. MOIs for the large scale liquid lysate were either kept as close to the previous 
MOI as possible. The amount of bacteria and phage used are listed below 
 
 
 
 
 
 
 
 
Phage Bacteria (cfu) ×10
7
 
Initial titre (pfu) 
×10
6
 MOI 
Final titre (pfu/ml) 
×10
9
 
Mozambique 1 15
 
20
 
0.07 20 
Mozambique 3 9
 
3
 
0.03 5
 
Caltech 1 60
 
20
 
0.03 1
 
Caltech 5 60
 
20
 
0.03 20
 
Botswana 1A 90
 
70 0.08 7
 
Botswana 1B 90
 
80
 
0.09 4
 
Botswana 2A 30
 
3
 
0.01 10
 
Botswana 2B 9
 
8
 
0.09 1.4
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Table 3.6 Amount of phage and bacteria used in the production of large scale liquid lysates 
and final titres  
 
3.2.3 Phage Purification 
 
Large scale phage lysates were centrifuged and phages in the supernatant were precipitated 
by adding NaCl and PEG. Precipitated phages was then collected in the pellet after 
centrifugation and re-suspended in a smaller volume of CS buffer. Phages were then 
purified by a CsCl equilibrium gradient of 1.50g/ml. All phages appeared as purple blue 
band located slightly above or below the middle of the tube, indicating that all phages have 
a density range of 1.40 – 1.60 g/ml. Purified phages were titred and compared with those of 
the large scale lysate to calculate the percentage of recovery: 
 
 
 
 
 
 
 
 
Phage Bacteria (cfu) ×10
7
 Initial titre (pfu) ×10
6
 MOI 
Final titre (cfu/ml) 
×10
9
 
Mozambique 1 15
 
20
 
0.07 3
 
Mozambique 3 3
 
1
 
0.03 5
 
Caltech 1 3
 
1
 
0.03 2
 
Caltech 5 6
 
2
 
0.03 10
 
Botswana 1A 9
 
7
 
0.08 6
 
Botswana 1B 4.5
 
4
 
0.09 10
 
Botswana 2A 10
 
1
 
0.01 7
 
Botswana 2B 1.5
 
1.4
 
0.09 10
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Table 3.7 Titres of both large scale phage lysates and the subsequent purification with 
recovery percentage 
Phage 
Titres of large scale lysate (pfu/ml) 
× 10
9 
Titres of purified 
phages (pfu/ml) × 10
11 
Recovery (%) 
Mozambique 1 3 3 20 
Mozambique 3 5 71 28 
Caltech 1 10 9 18 
Caltech 5 10 4.3 9 
Botswana 1A 6 3.3 11 
Botswana 1B 10 2.9 6 
Botswana 2A 7 2.3 7 
Botswana 2B 10 7 7 
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3.3 Phage Morphology 
 
Phages were negatively stained and viewed under a transmission electron microscope, the 
family of each individual phage, its head diameter, and its tail length and diameter is given 
in the table below 
 
 
 
 
 
       
 
 
 
 
    Mozambique 1             Mozambique 3        Caltech 1 
 
 
 
 
 
 
 
 
 
 
 
     Caltech 5      Botswana 1A   Botswana 1B 
 
 
 
Tail 
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    Botswana 2A          Botswana 2B 
 
Figure 3.2 Electron micrographs of phages 
Bar = 100nm. All micrographs are taken at 100 000× magnification, with the exception of 
phages Mozambique 3 and Botswana 2A, which were taken at 50 000× magnification. 
 
All phages observed are found to belong to the family Siphoviridae. Phage dimensions 
were measured and are tabulated below: 
 
Table 3.8 Summary of phage sizes 
Phage Head diameter (nm) Head length (nm) Tail length (nm) 
Mozambique 1 54 ± 3 56 ± 3 116 ± 3 
Mozambique 3 60 ± 0 60 ± 0 136 ± 24 
Caltech 1 52 ± 2 60 ± 0 150 ± 0 
Caltech 5 54 ± 3 56 ± 8 148 ± 7 
Botswana 1 A 54 ± 3 54 ± 3 114 ± 3 
Botswana 1 B 56 ± 3 58 ± 2 124 ± 3 
Botswana 2 A 60 ± 0 68 ± 6 124 ± 4 
Botswana 2 B 56 ± 3 60 ± 2 146 ± 3 
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The values above are the mean values obtained from measurements done on five different 
images of phage particle per phage. Statistical tests were performed using the following 
formula: 
  
 
 
S
2 
is the unbiased estimator of the samples. N is the sample size and X is any given 
measurement. 
 
In a review (Ackermann 2007) which examined the morphology of 5500 phages, it was 
established that almost all phages (96%) are tailed phages, and 61% of these phages belong 
to the family Siphoviridae. Within mycobacteriophages, all phages so far characterized 
have been double stranded DNA tailed phages and in a recent review (Hatfull 2010) of 70 
mycobacteriophages, belong to the family Siphoviridae, which are characterized by long 
non-contractile tails varying from ~105nm to ~300nm. The review also found that head 
shapes and sizes vary widely amongst these phages. Although most heads are isometric, 
three of the 61 phages contain prolate heads, with some heads having a length to width 
ratio of four. Ranges of head sizes range from the smallest of 48nm in diameter for phages 
BP and Halo to the largest of 85nm of phage Bxz1. Other than head sizes and shapes, 
structure of tail tips also vary from phage to phage.  
 
The remaining nine phages belong to the family Myoviridae, and both this family and 
Siphoviridae belong to the order Caudovirales. Hatfull has also noted the absence of the 
family Podoviridae, which can be explained either as an evolutionary constrains or a 
physical constrain in tackling the complex and thick mycobacterial cell wall during 
infection. 
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3.4 Phage Genome Sizes 
 
Genomic DNA of all 8 phages were extracted from their purified particles and genomes 
sizes calculated from gels obtained from pulse field electrophoresis. 
 
                    1            2          MW              1          MW          3 
    
            A          B 
Size (kb) 
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23.1 → 
 
 
 
 
9.42 → 
 
 
6.55 → 
 
 
 
 
4.36 → 
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6.55 → 
 
 
 
4.36 → 
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                         1        MW         2        3        MW      4 
      
             C      D 
 
Figure 3.3 Phage genomic DNA in 1% agarose gel in pulse field gel electrophoresis 
 
A Lane 1: Mozambique 1    B Lane 1: Botswana 1A 
 Lane 2: Mozambique 3     Lane 3: Botswana 2A 
 
C Lane 1: Caltech 1     D Lane 1: Botswana 1B 
 Lane 3: Caltech 5      Lane 3: Botswana 2B 
 
The genomic sizes of all 8 phages are given below: 
 
Table 3.9 Genomic sizes of phages 
Phage 
genomic size 
(kb) 
  
Mozambique 1 Mozambique 3 Caltech 1 Caltech 5 
41 39 57 57 
Botswana 1A Botswana 1B Botswana 2A Botswana 2B 
49 46 67 49 
Size (kb) 
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In a recent review (Hatfull 2010) of 70 sequenced mycobacteriophages, the genome size 
ranges from 164.60 kb (Myrna) to 41.44 kb (Angel) with the average genome size of 
73.60kb with an average of 114.9 ORFs. With the exception of Mozambique 1 and 3, all 
other isolated phages fall within the range of the 70 genome sizes reviewed. Various 
studies done on mycobacteriophages have shown that these phages exhibit a diverse and 
complex set of genomes and it remains to be seen whether there exist mycobacteriophages 
that has similar genome size to the two outliers found in this study. Botswana 1A genome 
shows at least four DNA bands of different sizes is due to whole phage genomes binding to 
each other. The results of Botswana 1A show that these various bands are proportionate 
relative to each other (See their position relative to marker). Genome sizes are determined 
by first measuring the distance a given band has travelled and plotted on a log graph of kilo 
base/base pairs versus distance travelled. 
 
3.5 Transduction 
 
Generalized transductions were performed using M. smegmatis double mutants that are 
resistant to both rifampicin and streptomycin. This is because the genes rpoB (at position 
1461630 – 1465139) and rpsL (at position 1498302 – 1498676) are closely linked (Figure 
3.3). Rifampicin mutants were produced by plating 200μl of stationary phase M. smegmatis 
MC
2155 onto LA media supplemented with 100μg/ml rifampicin and incubated at 37oC for 
48hrs or until colonies appear. A single colony was then picked and grown in LB 
supplemented with 100μg/ml rifampicin and incubated at 37oC for 48hrs or until it reaches 
stationary phase. 200μl of this liquid culture was in turn plated on a LA plate supplemented 
with 100μg/ml rifampicin and streptomycin and incubated at 37oC for 48hrs or until 
colonies appear. These mutants were used to produce plate lysates by incubating phages 
from liquid lysates with double resistant mutants with cfu/ml of 2 ×10
6
 and overlaid on 
LCM agar plates, incubated at 37
o
C for 48hrs and repeated twice. Phages from the plate 
lysate were collected using the same method describe above and titred. 
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Figure 3.4 Genome map of M. smegmatis showing the locations of rpoB (MSMEG_1397) 
and rpsL (MSMEG_1398)  
 
Table 3.10 Amount phage used in the production of lysate and final titres for transduction 
Phage Initial titre (pfu) ×10
5 
MOI Final titre (cfu/ml) ×10
9 
Mozambique 1 3
 
0.15 4
 
Mozambique 3 5
 
0.25 48
 
Caltech 1 20
 
0.01 4
 
Caltech 5 1
 
0.05 2
 
Botswana 1A 60
 
0.03 3
 
Botswana 1B 1
 
0.05 20
 
Botswana 2A 70
 
0.35 2
 
Botswana 2B 1
 
0.05 2
 
 
Phages were then mixed with non-resistant M. smegmatis at both MOI of 0.1 and 1.0. This 
mixture was then incubated at room temperature for 30 min. The mixture was then 
centrifuged for 5 min and the pellet re-suspended and spread on a LCM agar plate 
containing rifampicin and streptomycin at a concentration of 100μg/ml. Plates were then 
incubated at 37
o
C for 14 days and observed for bacterial growth every 2 days. No 
transductants were detected and therefore it could be concluded that the selected phages 
tested are not generalized transducing phages. 
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3.6 Restriction digest of phage genomic DNA 
 
Phage DNA was digested to screen for restriction endonuclease suitable for construction of 
genomic libraries. Restriction enzymes HindIII, BglII, PstI, and SfuI were tested, also 
included were isocaudomers of these restriction enzymes, such as BclI, NsiI, BamHI and 
XmiI. Results for all digestions are shown below. 
 
 MW   1   2    3   4     5   6    7   8     9   10         1   2    3   4     5    6    7    8    9  10  MW 
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MW 1    2     3    4    5    6    7    8    9  10           1    2    3    4    5    6    7    8   9   10  MW 
         
      Botswana 2A     Botswana 2B 
 
Figure 3.5 Digestions of phage genomic DNA by various restriction enzymes on 0.8% 
agarose gel. Lane numbers corresponds to the same enzymes on all gels. 1 HindIII;  
2BglII; 3 BamHI; 4 BclI; 5 PstI; 6 NsiI; 7 SfuI; 8 XmiI; 9 ClaI; 10 Undigested control 
 
Throughout the co-evolutionary history that bacteria have with phages, host cells have 
evolved a series of defense mechanisms to resist phage infection. One such mechanism is 
the restriction-modification, where foreign DNA (such as that from a phage) is degraded by 
host restriction enzymes (RE) upon entry into the cell. The host own genetic material will 
be protected by methylation through bacterial methylase. As such, phages have developed 
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several resistance mechanisms, such as the development of unusual bases, modification of 
bases and altering its sequence in order to defeat host restriction, with most of the research 
done on E.coli and B. subtilis phages 
 
For unusual bases, Bacillus subtilis phages PBS1And PBS2 incorporate uracil instead of 
thymine to protect the genome from degradation (Takahashi and Marmur 1963). The two 
phages encodes the protein Ugi, which mimics uracil containing double stranded DNA and 
interacts with host protein uracil-DNA glycosylase, a host protein that counteracts this 
sequence alteration by removing uracil bases from phage DNA (Wang and Mosbaugh 
1989). 
 
Modification of bases is another strategy employed by phages. An example of which can be 
found in phage T4, which methylates adenosine residues (Carlson et al 1994) and protects 
the genome from classical RE defence mechanisms. In addition, the phage replaces 
cytosine with a modified hydroxymethylcytosine (HMC) in its genome before being 
glycosylated. This protects the HMC from degradation by host Mcr restriction enzymes 
that were developed to cleave modified cytosine (Bickle and Kruger 1993). In response, 
another RE, GmrSD, was developed to specifically recognize and cleave glycosylated 
HMC and this lead T4 to encode for an internal head protein, IPI* to protect the genome 
against GmrSD through direct protein-protein interaction when it is injected into the host 
along with the genome (Bair et al 2007). A recent study indicates that host cell produces 
GmrSD that are insensitive to IPI* (Rifat et al 2008), highlighting a robust defence 
mechanism in response to phage attacks. 
 
For mycobacteriophages, restriction studies (Coene et al 1993) done on a series of M. 
smegmatis hosts shows phages such as 29M, 31M and 122 to have methylcytosine in the 
sites GGCC and CCGG, showing resistance to enzyme HaeIII and HpaIII. Other phages 
such as 154 and 110 are resistant to Sau3AI, MboI and HhaI due to the presence of 
methylated cytosine and adenine 
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3.7 Construction of Phage Genomic Libraries 
 
Four genomic libraries were constructed using three of the phages: Mozambique 1, 
Mozambique 3, and Botswana 2A. All libraries were constructed by transforming E. coli  
MM294-4 with pDA71And 20 clones from each library were randomly chosen (with the 
exception of Mozambique 3 PstI library, from which 60 clones were randomly chosen). 
 
3.7.1 Mozambique 1 PstI Library 
 
Genomic library of phage Mozambique 1 was constructed with endonuclease PstI, and 20 
clones were randomly chosen and plasmid mini preparation was done to extract these 
clones. 
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Figure 3.6 Twenty clones from Mozambique 1 PstI library shown on two 0.8% agarose 
gels. Inserts are bands below the upper row of bands, which are linearised pDA 71. 
 
Once the clones are obtained, calculations were performed to determine the average insert 
size and number of clones needed to have 95% probability of the library containing the 
Mozambique 1 genome.  
 
Average insert size = Sum of all insert size/number of clones isolated 
          = 22470 bp/20 
          = 1.124 kb 
 
To calculate the number of clones needed to have 95% probability of the library containing 
the phage genome, the following equation is used 
 
N = ln (1 – p) 
       ln (1 – a/b)   
 
   = ln (1 – 0.95)               
      ln (1 – 1.124/40.59)  
  
     = 105 clones 
 
The number of clones obtained from this library was 141. 
 
Where N is the number of clones, p is the probability of any phage DNA in the library and 
a and b are average insert size and the total phage genome size respectively. 
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3.7.2 Mozambique 3 PstI Library 
 
Genomic library of phage Mozambique 3 was constructed with endonuclease PstI.  
 
Sixty clones were randomly chosen and plasmid mini preparation was done to extract these 
clones 
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Figure 3.7 Sixty clones from Mozambique 3 PstI Library shown on two 0.8% agarose gels. 
Inserts are bands below the upper row of bands, which are linearised PDA 71. 
 
The average insert size was 0.47kb with 247 transformants needed to have a 95% 
probability of the library containing the Mozambique 3 genome. A total of 736 
transformants were obtained from this library. 
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3.7.3 Mozambique 3 BamHI Library 
 
Genomic library of phage Mozambique 3 was constructed with endonuclease BamHI.  
 
Twenty clones were randomly chosen and plasmid mini preparation were done to extract 
these clones 
 MW 1    2     3     4    5    6     7   8    9   10      MW 11 12  13  14  15  16 17  18  19  20 
       
 
Figure 3.8 Twenty clones from Mozambique 3 BamHI Library shown on two 0.8% 
agarose gels. Inserts are bands below the upper row of bands, which are linearised vector 
PDA 71 
 
The average insert size was 0.24kb with 499 transformants needed to have a 95% 
probability of the library containing the Mozambique 3 genome. A total of 601 
transformants were obtained form this library. 
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3.7.4 Botswana 2A BclI Library 
 
Genomic library of phage Botswana 1A was constructed with endonuclease BclI.  
 
Twenty clones were randomly chosen and plasmid mini preparation were done to extract 
these clones 
             MW  1   2    3   4    5    6    7   8    9   10   11MW12  13 14 15 16 17 18  19 20 
     
 
Figure 3.9 Twenty clones from Botswana 2A BclI Library shown on two 0.8% agarose 
gels. Inserts are bands below the upper row of bands, which are linearised vector 
PDA 71 with the exception of clone nos. 8 and 14, in which case the insert is positioned 
above the linearised vector. 
 
The average insert size is 2.924kb with 67 transformants needed to have a 95% probability 
of the library containing the Botswana 2A genome. A total of 642 transformants were 
obtained for this library. 
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3.8 Screening of Libraries for Clones with Antimicrobial Properties 
 
Clones from libraries made from phages Mozambique 1And 3, along with phage Botswana 
1A were screened for antimicrobial activity by transforming these clones into R. 
erythropolis SQ1By PEG mediated transformation. With the libraries of phage 
Mozambique 1And Botswana 1A, all twenty clones were screened. With Mozambique 3, 
11 clones with inserts were selected screened. The modified vector pDA71*, which is a 
pDA71 vector with the EcoRI suicide gene removed, was used as the positive control. 
 
3.8.1 Screening of Mozambique 1 PstI Library Clones with Antimicrobial Properties 
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Fig 3.10 PEG mediated transformation of R. erythropolis SQ1 of 20 clones isolated from 
PstI Mozambique 1 library. Numbers on the plate corresponds to the numbers of the clone. 
“+” denotes the positive control of pDA71* and “-“denotes negative control 
 
Table 3.11 Transformation efficiencies for twenty clones isolated from Mozambique 1 PstI 
library  
 
Clone # Transformants/μg of DNA 
1 441 
2 76 
3 156 
4 32 
5 3 
pDA71* control 2027 
 
Clone # Transformants/μg of DNA 
6 < 1.64 
7 385 
8 < 0.9 
9 2 
10 16 
pDA71* control 940 
Clone # Transformants/μg of DNA 
11 11 
12 822 
13 104 
14 750 
15 387 
pDA71* control 1000 
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3.8.2 Screening of Selected Clones from Mozambique 3 PstI Library for Antimicrobial 
Properties 
 
Of the clones isolated from phage Mozambique 3 PstI library, only selected clones with 
inserts were screened for antimicrobial activities. 
 
  
 
Figure 3.11 PEG mediated transformation of R. erythropolis SQ1 of 11 selected clones 
isolated from PstI Mozambique 3 library. Numbers on the plate corresponds to the numbers 
of the clone. “+” denotes the positive control of pDA71* and “-“denotes negative control 
 
 
Clone # Transformants/μg of DNA 
16 7 
17 41 
18 7 
19 125 
20 616 
pDA71* control 767 
42 
44 
45 48 57 
+ - 
22 29 30 
33 38 
40 
+ - 
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Table 3.12 Transformation efficiencies for selected clones isolated from Mozambique 3 
PstI library  
 
 
 
Clone # Transformants/μg of DNA 
22 < 3 
29 < 4 
30 743 
33 1522 
38 20 
40 < 3 
pDA71* Control 860 
Clone # Transformants/μg of DNA 
42 < 12.5 
44 5 
45 1174 
48 748 
57 18 
pDA71* control 1447 
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3.8.3 Screening of Botswana 2A BclI Library Clones with Antimicrobial Properties 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 PEG mediated transformation of R. erythropolis SQ1 of 20 clones isolated 
from BclI Botswana 2A library. Numbers on the plate corresponds to the numbers of the 
clone. “+” denotes the positive control of pDA71* and “-“denotes negative control. 
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Table 3.13 Transformation efficiencies for 20 clones isolated from Botswana 1A BclI 
library 
 
Clone # Transformants/μg of DNA 
1 291 
2 67 
3 110 
4 205 
5 90 
pDA71* control 873 
 
 
 
 
 
 
Clone # Transformants/μg of DNA 
6 110 
7 80 
8 123 
9 188 
10 71 
pDA71* control 500 
Clone # Transformants/μg of DNA 
11  89 
12 113 
13 449 
14 60 
15 514 
pDA71* control 413 
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Clone # Transformants/μg of DNA 
16 400 
17 72 
18 314 
19 313 
20 100 
pDA71* control 593 
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3.9 Analysis of Inhibitory Clones 
 
Several clones that showed inhibitory activities from PstI libraries of phages Mozambique 
1And 3 were selected for further analysis. Inserts from these clones were extracted from 
0.6% agarose gel, purified, ligated into vector pUC18/19. These inserts in pUC18/19 was 
then transformed into E. coli MM294-4 and sequenced. Sequencing was done by Inqaba 
Biotech. 
 
Sequencing was done from both forward and reverse direction to ensure the coverage of the 
entire insert. Forward and reverse sequences was aligned through EMBOSS Needle global 
pairwise alignment. The sequence was then analyzed using BLASTn to determine the 
nucleotide sequence similarity of each clone to those on the database and BLASTx was 
used to determine the amino acid sequence similarity.  
 
Open Reading Frames (ORFs) in each clone was then predicted using GeneMark and 
Softberry. The former is a heuristic approach using small amount of prokaryotic nucleotide 
sequence to build up various Markov models. This can be used to find ORFs in small 
fragments of sequences from unknown prokaryotic organisms to viruses and phages and 
even organelles and plasmids (Yok and Rosen 2011). The latter also uses a Markov chain-
based gene prediction in viruses. The ORFs reported below are the results taken from both 
programs. 
 
Once the ORFs are predicted, protein sequences of the ORFs were analyzed using BLASTp 
to determine protein-protein sequence similarities with those in the database. Clones were 
also analyzed for restriction sites using NEB cutter in order to determine the minimum 
amount of DNA needed for inhibitory activities. This was done to screen for any relevant 
enzymes that can be used to digest the inserts in order for these fragments to be re-cloned 
back into vector pDA71 for transformation into R. erythropolis SQ1. Restriction 
endonuclease screened is the same ones used in various digest of phage DNA for the 
construction of phage genomic libraries.  
 
 67 
3.9.1 Clone 5 of Phage Mozambique 1 PstI Library  
 
Insert of clone 5 were extracted from a 0.6% agarose gel, purified, cloned into the PstI site 
of vector pUC18/19 vector and sequenced. The sequence is shown below 
 
ctgcagtggc gccgcgtarg acgggttgca ccagacgcgg atgtgcttgg tctgagccat gtcgtgcaaa aacmcgmcct 
cgaggtaagc gtcaccggaa tcggtcttga cgacccggta gtggtccatc atcccggtcc accgagcgcc ttgcttctcg atgttgatga 
tgacgttccg ctttgctcga ccacggtggt tcatgaccca cttggccagg tagtggctca gcgagagctg aagggtcgcg 
gtgcccacgt cgttctcgat gaactcccac tcgagcaacc gctcgccagc gaccacgcct cggaggcgga agtcgccgtc 
gcgcagctct acgtcggccg gtgccagacg tgcggcctcg cgcttggcgc ggcgctgttg gatgagcttc caragatcgt 
tggcctgaga gactgacttc agaccactca ctcgagcccc cagcagcgcg tccacggcct gggaagccga agggtcacta 
cctgtcccgg agcgcatccc gaggcgtcta tgacgaactc agcctcttcg gtgtacggcg ggatctggtt gcggaaccgg 
acgccgttca tgcgagccca cacaggcgag cccgactcgg aagcgatctg ctcctcgcgg cgatcggtgt cgatcacgca 
gttctcgccg tagatcaagc cagggagctt gagccggcgg ttggcggaaa ctccttcgtt cttcgatcga agtaagttca ggaatgacga 
actgagtgaa tcggagctgt ttcccacggg atcggcgtgt tcggagggaa cggcccaggr ggaagttggg caccttctcg 
gtggagccgg gaacggtcca cttcggggcg atgtactggt cggtggggtt gagcccacct tgtccacggc cgaccttgat 
ccgcagcgtc tccttgggca gttcctccca cggccacgg cggcgtccag aacgacgggt cgaaccgggt gtcggtcttc 
gtcttggccg agaagacgcg atcgtycttc ccaccagaac gggtcgtacg cgatgcacga catccaccgg tcagggttga 
tgctgtttgc ctcgcgggtc ggtctttcat cytcgacttg gggggactcg aacaggaccg gcaccttgaa ggtagcgcgt 
accggagtcc ggggtggtg  acgtagatct tgcagtcgcg gttgaacgcc cacgccttgc gccactcgc tgtcacgcga 
gagccacgac cggggtccgc tcttggcatc gttgaggatc tgaaccccga agacgatgtc ccgcttcagg atccggtgcg 
acaagtagcg agcgccgggg tagttccccg gctcctcaat cacgaccttg acgggagggt cgtagaaaca accctccacg 
tctgtggcca ggaacacgcc ctggtcaccg gtcgtcagat tgaagaactc accattgaca ccctcgagtt caacgatggt gtcggtgatc 
aatgcttacc tcctggtgaa tgtcaagttc gcggcctact gacggccgac gactgcgagt gcgctcttgc tctcttcgcg gtccttgatc 
gacagagcct catcgaccga gccgatgttg aacacgtacg agatgccctc ggtgatggcc ttcgagatga atccctcacc 
agagatgccg atgtccgaaag gaactgcttg ccagtcgctt tcgcgaagtc gaccggggag gccatcatct tggcgacttg 
gtcctccagc gacataccct tcgatccctc agcggtctcg tcgkkgtagt cgcctacgag gtcgagcaga tccttttgag cctgcag 
 
Figure 3.13 Sequence from clone 5 of Mozambique 1 PstI library with PstI site highlighted 
in orange. 
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BLASTn result 
 
 
 
Figure 3.14 BLASTn search result from clone 5 of Mozambique 1 PstI library when aligned with known sequences from the 
database. Where “scores” are similarities between the query and the matches found in the database and “Total score” is the sum of all 
scores between the query and high scoring hits, “Max score” is similar to E (Expected) value. This is the number of hits one is 
“expected” to see when searching the database for a particular length that is the same as the query. This is dependent on both the query 
length and hits in the database. The closer the E-value is to zero, the more significant the hit. “Coverage” deals with the percentage of 
coverage of the query and “Max Ident” is the highest percentage identity of highly similar pairs. 
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BLASTx result 
 
 
 
Figure 3.15 BLASTx search result from clone 5 of Mozambique 1 PstI library when aligned with known protein sequences from the 
database. 
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ORF prediction and construction of restriction map 
 
Open reading frames were predicted using both GeneMark and SoftBerry, a given ORF is 
accepted when there is a consensus between the results from the two programs. Clone 5 
has two ORFs, with ORF1 occupying the position between 1086 to1469 and ORF2 from 
1503 to 1805. A restriction map of the insert is also drawn after analyzing the sequence 
using NEB cutter showing the location of the restriction sites and the positions of the two 
ORFs. 
 
 
 
Figure 3.16 Restriction map of clone 5 of Mozambique 1 PstI library along with the 
positions of the two predicted ORFs 
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BLASTp results of clone 5 ORFs 
 
The two ORFs of clone 5 were analyzed to determine any similarity to proteins in the database; both L5 gp27 and Trixie gp29 are 
minor tail subunits. 
 
 
ORF1 
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ORF2 
 
Figure 3.17 BLASTp search result of ORFs 1 and 2 from clone 5 of Mozambique 1 PstI library when aligned with known protein 
sequences from the database. Blast results for all BLASTp (protein-protein) query does not provide “Max Ident”.  
 
Tail like bacteriocins produced by both gram positive and negative bacteria, have been previously described in several studies (Gratia 
1987; Krügel et al 1987; and Muňoz et al 1987). Two types of such bacteriocins have been described: One being a contractile tail like, 
similar to tails of T-even phages (R-type) and a non-contractile but flexable tail like similar to those found in λ phages, or those 
belonging to the family Siphoviridae (F-type) (Michel-Briand and Baysse 2002). It has been proposed (Kageyama 1985) that these 
bacteriocins were once defective phages. Later studies confirmed (Nakayama et al 2000) that R and F-type produced by P. aeruginosa 
have common ancestral origins with phages P2And λ respectively. Hence, these defective phages were later adopted and specialized 
as bacteriocins.
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Determining minimal amount of DNA needed for antimicrobial activity for clone 5 
 
Clone 5 was digested with both PstI and BglII in order to release the insert and also to 
obtain two fragments. The BglII - PstI fragment contains ORF2 along with a sizable of 
ORF1 with a size of 650bp. The PstI – BglII contains a stretch of sequences with no 
predicted ORFs but it does contain a small piece of ORF1 with the size of 1150bp. These 
two subclones was re-ligated back into vector pDA71And transformed into E. coli 
MM294-4. Five colonies were picked from each of the two transformations and screened 
for inserts 
 
                  MW   1     2    3     4     5          6     7     8    9    10 
 
 
Figure 3.18 Subclones from clone 5 of Mozambique 1 PstI library: PstI – BglII are in 
lanes 1 – 5 and subclone BglI – PstI are in lanes 6 - 10. Inserts were released after 
digestion with BglII and run on a 0.8% agarose gel.  
 
Both fragments was transformed into R. erythropolis SQ1 to determine the minimal 
amount of DNA needed for antimicrobial activity 
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Table 3.14 Transformation efficiencies for both subclones of clone 5 from Mozambique 
1 PstI library 
Restriction sites at the end of subclone inserts Insert size (bp) Transformants/μg DNA 
PstI – BglII 1150 < 6 
BglII – PstI 850 910 
pDA71* control N/A 800 
 
3.9.2 Clone 6 of Mozambique 1 PstI Library 
 
Insert of clone 6 were extracted from a 0.6% agarose gel, purified, cloned into the PstI 
site of vector pUC18/19 vector and sequenced. The sequence is shown below. 
 
ctgcagcagt tgccagatac atcgcggtcg tggtcttacc cacgccgccc ttcgtgtgaa ctaccgagat cgttgtcatg 
atcggatcgt actcgaatcc tcgaggactag aggtctcgac accccgagga ctcgaaaact cgaggtctcg 
actactcgat agtcgactaa tcgacaactc gactaatcga tgcaggtcar agacacgcct gtcggggcaa atgcggcggt 
tgtgactcgt tcgggaggaa gatcagcgcg accgaacaac tccataaacg acgaaacccc ctgttggcgc 
agggggctgt ctgtcccgaa gggaacgatg acttggacgt ctcgtttcac ggtagcgcac gcctccgaca 
agcggaagct gcgacacgaa accgtgatgc atttcgtaac tggcttgggc gagctggcgc gtcggccgcg 
ccgcgatggg tgtctcgcga gcagtggctt aaggacgtga ccgagtggtc gcgatccgac cgattcaccg 
cctgcggcat ctcgatggac cccatgacct tcatggcgat catgcgggtc atggccgact acgcagacca 
ctcagacggg cgctgtgtgg ccgtctcccg gtccagaatc gcttccgcag tgggttgtgc gcccggaacg 
gttacgcggg cctggaggct cctacggytc tccgggtacg ggatcgaggt ccagcgcggc cacggctccg 
accggacgcc ctcgcagggg tgccggccgt cgatctacca ccttgtgagt aaacgccgtc cggttgtgga caatgttcac 
ctaccgccga aggcggcagt agttctctct tctcccgtag ggaggtactc accaagggcc gctgcgcggc 
cgcgaaagat gcctcgaaag ggaaagacaa ccccggccga tcgagctgcag 
 
Figure 3.19 Sequence from clone 6 of Mozambique 1 PstI library with PstI site 
highlighted in orange
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BLASTn results 
 
The sequence was then analyzed using BLASTn to determine whether it shares any nucleotide sequence similarities with sequences in 
the database. 
 
 
 
Figure 3.20 BLASTn search result from clone 6 of Mozambique 1 PstI library when aligned with known sequences from the database 
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BLASTx results 
 
The sequence was also analyzed using BLASTx to determine whether it shares any similarities with protein sequences in the database.  
 
 
 
Figure 3.21 BLASTx search result from clone 6 of Mozambique 1 PstI library when aligned with known protein sequences from the 
database. These results are shows that although it has a nucleotide match to known mycobacteriophages, the BLASTx results shows 
that the insert share sequence similarities with several mycobacterial proteins. 
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ORF prediction and construction of restriction map 
 
Open reading frames were predicted using GeneMark and SoftBerry, a given ORF is 
accepted when consensus is reached between the results from the two programs. Clone 6 
has two ORFs, with ORF1 occupying the position between 2 to 79 and ORF2 from 184 to 
351. A restriction map of the insert is drawn after analyzing the sequence using NEB 
cutter showing the location of the restriction sites and those of the two ORFs. 
 
 
 
Figure 3.22 Restriction map of clone 6 of Mozambique 1 PstI library along with the 
positions of the two predicted ORFs 
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BLASTp results of Clone 6 ORFs 
 
The two ORFs of clone 6 were analyzed to determine any similarity to proteins in the database. Phage Hammer gp37 is a hypothesised 
parA protein dealing with chromosome segregation. 
 
BLASTp result of ORF1 from clone 6 
 
 
 
Figure 3.23 BLASTp search result from ORF1 of clone 6 of Mozambique 1 PstI library when aligned with known protein sequences 
from the database. 
 
BLASTp result of ORF2 from clone 6  
 
BLASTp results from the predicted ORF shows no significant sequence similarity with protein sequences from the database.
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During bacterial replication, chromosomal DNA are separated and moved towards the 
opposite poles of the host. Chromosomal segregation is further aided by homologues of 
two plasmid partitioning proteins, ParA and ParB, which orientate the origin of 
replication to towards the poles (Sharpe and Errington 1997; Mohl and Gober 1997). 
Both proteins are found in plasmids (as SopA) and the bacteriophage P1 which is used for 
DNA segregation when P1 is replicating itself as a plasmid prophage (Gordon and Wright 
2000). ParA is an ATPase that acts as a tracriptional repressor by binding its helix turn 
helix sequence upstream of a parAB operon (Gordon and Wright 2000). Experiments 
(Easter and Bober 2002) have shown that an overexpression of ParA prevents cell 
division. 
 
Determining minimal amount of DNA needed for antimicrobial activity for clone 6 
 
Clone 5 was digested with both PstI and NsiI in order to release the insert and also to 
obtain two fragments. The NsiI - PstI fragment is 522bp with no predicated ORF located 
in it. The PstI – NsiI contains a stretch of sequences with both ORFs in a short sequence 
of 400bp.These two subclones was re-ligated back into vector pDA71And transformed 
into E. coli MM294-4. Five colonies were picked from each of the two transformations 
and screened for inserts 
         MW  1   2  3   4  5    6   7   8   9  10 
         
Size (bp) 
 
20000 → 
 
5000 → 
 
 
 
 
1500 → 
 
1000→ 
 
 
700 → 
 
500 → 
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Figure 3.24 Subclones from clone 6 of Mozambique 1 PstI library: PstI – NsiI are in 
lanes 1 – 5 and subclone NsiI – PstI are in lanes 6 - 10. Inserts were released after 
digestion with BglI and run on a 0.8% agarose gel. Lanes 6 – 10 all contains subclone 
NsiI – PstI while only lanes 1And 3 contain subclone PstI – NsiI. 
 
Both fragments was transformed into R. erythropolis SQ1 to determine if these subclones 
are able to exhibit antimicrobial activity 
 
Table 3.15 Transformation efficiencies for both subclones of clone 6 from Mozambique 
1 PstI library 
 
 
 
Restriction sites at the end of 
subclone inserts Insert size (bp) Transformants/μg DNA 
PstI – NsiI 400 2 
NsiI – PstI 522 5 
pDA71* control N/A 800 
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3.9.3 Clone 22 of Mozambique 3 PstI library 
 
Insert of clone 22 were extracted from a 0.6% agarose gel, purified, cloned into the PstI 
site of vector pUC18/19 vector and sequenced. The sequence is shown below. 
 
ctgcagccc ccgtastaat mcgttctgca tgatcagctt cctaatcgcc ccgacggcga tccgcacgtc ttgctcgaac 
acctccccca gctccaccgg cacgacccag gactcgtcgt gagtcccgaa ctggacgagg cggcacgcga 
acgtgtcgct gtagatgtcc agcccggtgg tctcggtgtc gacggcgagg cagttcarat gagcccggat 
gaagtcgcgg aagccgtcca gatcctctgg gtgctcaac gacgttgatg gtgacgaggt ctcctccgac ctcatgccgt 
agctcgatca tcttctctcc tagctgtatg ggtttcgctc gacgctggcc ttcgagtagt ggcggctctg gtggtcggtg 
tggacgaccg ggccgcaaac tcccttgtgg gccttgccat ctgcgtagaa caggacgccg atcaggttgt 
gctgccacag agacagcagc ccgaactcac ccatgtccaa ggtggctgag gtcggtggtc cgcgtccgt 
atcggcaacg tgttctcgtc cacatcagcg atctcgctca tgaggttgat cgccttgcgg cgcaggttga ctccctggac 
atcgagcggc agagcggggt cgatcggctc cgcgatcatg acccggattc ggtctgccat cagtggtaga 
tcccccggac ggtgcgcgag atcgtggccg ggttcacgcc gtagttgcgg gcgagatcct ttctgcttcg cgccgccgta 
gtaggcgtca cgaatgtcct tggcctcggt ctcggtgagc ttgcggcggt tcggccggct cgggccggtg 
ggagcctgcg gctcgccctt gacgaacgcc tctccgaagc atcgcttggc ggtctcgagc tgccgcttca ggtcgtggtt 
ggaccggatg gcgctgttcg cgacagcccg acagcttcac attgggccgc atgaaagctc tgcgttcttc 
gcccgcacgg tgatcagctc cccgaacggt ctggttgttc tcgggcctcc agcgaggcgc tgaactcctt ctccgctgcc 
agctcagctc gcartgcttt tcttcgtctt ggtatgccat cagttgggcc tcctgcctga atttggctcg tactcttc-t 
tcggtcaatg tagtagaagt cgatgacctt gtcccagttg aaagttcggg acgtgccgtc atcgaacgcg atgatcagga 
caccctcggt ggtgtcgagg atcggctcac ccgcgatgat gtgataccgg tcctcgaggt tcgccacggt cgctcgtcgt 
gcttgcatgt cagcctccgt acggctcgtc ggggatgtcc tggtaggagt tgggagcgat ctcccggagc 
tgccgcagca gttcccctgc cagttcacgg atttcggcat ccgcggcctc gtgccagcgg gccttgatga cgttgcgcca 
cgcccggtgg ttgccggtg acgaccatcg gtgagttcgt catgttcggc aggaccgcac gggctgcctc acgaacctgc 
ttgcggggca agcccttcgc cgtgaggtgg tccacgatcg tcccgtaggt cgtcgtggct agatcccaga tgagctgcag 
 
Figure 3.25 Sequence from clone 22 of Mozambique 3 PstI library with PstI site 
highlighted in orange. 
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BLASTn results 
 
The sequence was then analyzed using BLASTn to determine whether it shares any nucleotide sequence similarities with sequences in 
the database. 
 
 
 
Figure 3.26 BLASTn search result from clone 22 of Mozambique 3 PstI library when aligned with known sequences from the 
database 
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BLASTx results 
 
The sequence was also analyzed using BLASTx to determine whether it shares any similarities with protein sequences in the database. 
No sequence similarity was found 
 
 
 
Figure 3.27 BLASTx search result from clone 22 of Mozambique 3 PstI library when aligned with known protein sequences from the 
database.
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ORF prediction and construction of restriction map 
 
Open reading frames were predicted using both GeneMark and SoftBerry, an ORF is 
accepted when there is a consensus between the results from the two programs. Clone 22 
has four ORFs, with ORF1 occupying the position from 1 to 310; ORF2 from 319 to 483, 
overlapping with ORF3, which starts from 476 to 658. ORF4 lies further away, 
occupying a position from 1298 to 1596. A restriction map of the insert, along with the 
location of the predicted ORF and the restriction sites is drawn after analyzing the 
sequence using NEB cutter. 
 
 
 
Figure 3.28 Restriction map of clone 22 of Mozambique 3 PstI library along with the 
positions of the four predicted ORFs 
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BLASTp results of Clone 22 ORFs 
 
The four ORFs of clone 22 were analyzed to determine any similarity to proteins in the database. 
 
 
ORF1 
 
 
 
ORF2 
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ORF3 
 
 
ORF4 
 
Figure 3.29 BLASTp search result of ORF1, 2, 3 and 4 from clone 22 of Mozambique 3 PstI library when aligned with known protein 
sequences from the database.
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Redrock gp46 is a DNA polymerase I with both a 3’ – 5’ exonuclease and a polymerase 
domain. It is involved in the replication in both bacteria (E. coli) and phages (T4) (Moser 
et al 1997) and is vital in steps such as proofreading, repair, DNA processing and 
stability. In E. coli, the exonuclease domain is comprised of three residues (Asp-355, 
Asp-424 and Asp-501) (Reha-Krantz and Nonay 1993). Although the 3D structure of 
both bacterial and phage of this domain are structurally the same, their protein sequence 
shares very little similarity, and mutations at this domain results in limited proofreading 
activity (Moser et al 1997).  
 
In phage Φ29, other than 3’ – 5’ activity and DNA polymerization, polymerase of this 
phage can also perform polymerization reversals and it can also replicates phage DNA 
without the use of Okazaki fragments or DNA helicases (Blanco and Salas 1996), making 
it highly processive (>70 kb) during phage replication.  
 
It could be suggested that such high processivity during replication ensures the phage will 
have numerous copies of its genome shortly after infection. This could link to high 
processivity of transcription of certain phages such as T7. In phage T7, transcription of 
phage genes are 5 fold faster than those of host genes, resulting in long lines of phage 
mRNA (Marchand et al 2001). Other phage proteins, such as RNase III and gp0.7, will 
also work in conjunction with phage mRNA to enhance its stability and assist in 
translation (Roucourt and Lavigne 2009) 
 
Increase in the replication of phage genome could also influence the replication of the 
host. Studies have shown that some phages redirect many of the host replication 
machinery in order to replicate its genetic material (Friedman et al 1984). However, other 
studies (Powell et al 1992) have also shown that c6A, a phage that infects Lactococcus 
lactis, rapidly degrades host cell DNA and incorporates them into phage progenies. The 
high processivity exhibited by Φ29 could help ensure rapid degradation of host DNA as 
seen in phage c6A. 
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Benedict gp44 is a thymidylate synthase complementary protein (ThyX/Thy1), which has 
the same function as thymidylate synthase (TS) although it shares no homology with it. 
TS is encoded by the gene ThyA, which is responsible for the de novo synthesis of 2'-
deoxythymidine 5'-monophosphate through the methylation of 2'-deoxyuridine 5'-
monophosphate, thereby making the enzyme essential for DNA replication 
(Sampathkumar et al 2005). Although it has been thought that TS was responsible for this 
in all organisms, genomic studies into several bacterial and archeal genomes has not 
found genes coding for TS (Myllykallio 2003). This leads to the discovery of another 
enzyme (ThyX/Thy1) that carries out the same function (Myllykallio 2002). Due to its 
importance in DNA replication, it is a conserved sequence in pathogens such as 
Helicobacter pylori, and in mycobacterium such as M. leprae and M. tuberculosis, and 
has widely considered to be a target for any future antimicrobial drugs.  
 
M. leprae and M. tuberculosis has both ThyA and ThyX gene, and has been hypothesized 
that the cell will use either one depending on different growth conditions (Purwantini et 
al 1997). ThyX is also reported to be in mycobacteriophages D29 and D5 (Myllykallio 
2002) and it could be suggested that these genes found it’s way into the phage genome 
either through packaging or through co-evolution with their bacterial hosts, especially a 
viruses that seeks to increase its replication speed and efficiency. This is true for viruses 
that has no access to thymidylate in the early stages of the infection, with an example of 
this being Paramecium bursaria chlorella virus-1 (Graziani et al 2004). 
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3.9.4 Clone 29 of Mozambique 3 PstI library 
 
Insert of clone 29 was extracted from a 0.6% agarose gel, purified, cloned into the PstI 
site of vector pUC18/19 vector and sequenced. The sequence is shown below. 
 
ctgcaggcsg gtkgtgggag gagattccgc gagccatctt gaggatcctct cctgatggcc tacgtcaacg 
gggccatcat cctctggggc ttcttcacct ggctcagcct ggtgctcgat caccgagagg agcgtgatcg tgcccgcgaa 
gcggaagccg ccggccaggc cgaaagctcc taagcagtgc gtcgattgcg ttgctgaggg gatcacgtcg 
aagcgcaaga ccccacaccc cggtcctcgg tgcgtaacgc actggcgggc caagaagcgc gagcgcagct 
cgggcgcgtg gggcgcgaga atccaagcca cgtatggcat tacggctgac gagtactggg cgatctacga 
gttccagggc ggtcgctgct acatctgcca gcgtgcgaac gggaaggtga aacgactat cggtagacca 
tgaccacaag acgggcatca tccgagggct gctctgcac gatgtgcaac aagtacaccc tgggctgggc 
gagggactgc atcgagttct tcaagcgggc catcgcgtac ctgacgaatc ctcctgcggt gcaagtcatc 
ggggagcgca tcgctcccat cgaggctgaa aggctgaccc gaacttgaca gccaccagcc cgatcgcagt 
agccatccag cggtactacc cggactggga agcaccgccc gatcacaacg agtggaacaa gtgcctgtgc 
ccgttccacg gcgacgaaac gccgtctgcc gcagtcagtt acgacctgcag 
 
Figure 3.30 Sequence from clone 29 of Mozambique 3 PstI library with PstI site 
highlighted in orange. 
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BLASTn results 
 
The sequence was then analyzed using BLASTn to determine whether it shares any nucleotide sequence similarities with sequences in 
the database.  
 
 
 
Figure 3.31 BLASTn search result from clone 29 of Mozambique 3 PstI library when aligned with known sequences from the 
database 
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BLASTx results 
 
The sequence was also analyzed using BLASTx to determine whether it shares any similarities with protein sequences in the database.  
 
 
 
Figure 3.32 BLASTx search result from clone 29 of Mozambique 3 PstI library when aligned with known protein sequences from the 
database 
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ORF prediction and construction of restriction map 
 
Open reading frames were predicted using GeneMark and SoftBerry, an ORF is accepted 
when a consensus result is reached from the two programs. Clone 29 has three ORFs, 
with ORF1 occupying the position from 56 to 184; ORF2 from 471 to 617, and ORF3, 
which starts from 614 to 760. A restriction map of the insert is also drawn after analyzing 
the sequence using NEB cutter. The positions of the three OFRs are also shown on the 
map. 
 
 
 
Figure 3.33 Restriction map of clone 29 of Mozambique 3 PstI library along with the 
positions of the three predicted ORFs 
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BLASTp results of Clone 29 ORFs 
 
The three ORFs of clone 29 were analyzed to determine any similarity to proteins in the database. ORF1 did not show any significant 
similarity. 
 
 
ORF2 
 
 
ORF3 
 
Figure 3.34 BLASTp search result of ORF 2 and3 from clone 29 of Mozambique 3 PstI library when aligned with known protein 
sequences from the database. 
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Recognition of DNA junctions and resolving them is essential to DNA recombination and 
repair, and enzymes that carry out this function have been seen in all forms of life 
(Raaijmakers 1999). In mycobacteriophage Che12, this function is carried out by 
endonucelase VII encoded by gp63, to which ORF 2 of clone 29 shares similarity. This 
enzyme has been extensively studied in the phage T4, which is expressed at early and late 
stages of infection and is involved in solving junctions (such as Holiday junctions) 
(Mizuuchi 1982), mismatch repair, and resolving branch points prior to packaging into 
phage heads (branching is also a feature in DNA recombination) (Solaro et al 1993; 
Grebenshchikova et al 1994). As such, T4 phages that carry a mutation of this gene will 
result in defective packaging with heads containing highly branched DNA and also 
reduced DNA replication (Raaijmakers 1999, Miller et al 2003). 
 
Like other resolvases, it acts as a dimer, and nicks branched DNA on both strands while 
working with DNA polymerase and ligase to repair DNA. Although it carries out the 
basic responsibilities of a resolvase, endonuclease VII is also involved in resolving Y-
junctions, heteroduplex loops, single strand overhangs and single base mismatches, all 
this suggests that endonucelase VII is descended from an ancient class of repair enzymes 
(Kemper 1997, Raaijmakers 1999).  
 
It is important to note that a resolvase found in T4, is also found in other bacteriophages 
such as T7, RusA, and Rap (Sharples 2001). This is due to recombination being an 
important process of both phage replication and evolution. During infection, 
recombination is needed to initiate DNA replication in T4 (Mosig 1998). It is also 
important to repair any damage DNA in order to increase the efficiency of replication to 
maximize the number to phage progeny. Recombination also plays a very important role 
in phage evolution, as seen by the presence of many recombination enzymes encoded by 
phages (Sharples 2001). This is essential for any genetic exchanges between phages and 
acquiring new beneficial genes, further enhancing the mosaic makeup already seen.  
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For ORF3, it bears similarity to gp61 of phage Turbido, a DNA primase. This enzyme 
produces primers during DNA replication by synthesizing oligoribonucleotides de novo 
on single strand DNA. In phages T7 and T4, DNA primase recognizes a trinucleotide 
sequence of 3’-CTG-5’ and 3’-T(C/T)G-5’ respectively and begin synthesis of primers at 
these sites for DNA polymerase to produce a nascent leading and lagging strand 
(Kusakabe and Richardson 1996). All primase have a potential metal binding site, and for 
both phages, this site is on the N-terminus of the primase and has been shown to be a zinc 
motif (Mendelman et al 1994). This motif is important in two ways: To maintain a stable 
bind between the DNA and the primase in such a way that the catalytic domain can 
synthesize the primer and to recognize the primer recognition site and synthesizes a 
primer of 4 – 5 bp long (Kuchta and Stengel 2010). In addition, to stimulate activity, 
primase are found to be coupled their activity with another enzyme such as helicase. In 
T7, a single primase protein can carry out both primase and helicase activity (Frick and 
Richardson 2001) 
 
 
Figure 3.35 Model of T7 primase-helicase hexamer showing zinc binding domain 
(Adopted from Kuchta and Stengel 2010) 
 
Due to its essential role in DNA replication, primase, like TS, are now considered to be 
an important antimicrobial target. Some have been synthesized using oligonucleotide 
analogues (Kutcha et al 1992) while others exists naturally (Wilson and Trauner 2007). 
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3.9.5 Clone 42 of Mozambique 3 PstI library 
 
Insert of clone 42 were extracted from a 0.6% agarose gel, purified, cloned into the PstI 
site of vector pUC18/19 vector and sequenced. The sequence is shown below. 
 
ctgcaggat cgtggccaga gtcgctgtcg gacgatcagt tcaacggtcg caacctctac tcgtcggaca acgtcaagga 
cgctctcgac aacgtgtcga ccaatcggta cctggtggac atcttgccga gggctctgga ggcgctggcc 
gagaagaacg agggccaggc cgaggcgatc aggagccgct acgaggacgg gatcgtgccg tccaagaagg 
acggcgcagc gatgctgctg tctcgggcgg tcaagtcgct gaccgaaggc acgttcaaca ttcatcgcga 
tcacctccgg tgtcgacgct gacggcaaac gtcaccgagg gtccggggag ccggcactca gtgttcccgg 
agacccgccc caccagcggc gggcactccg atccgacggc cgacatcgcg atcctgctga tcgagcatcc 
cgagctgcgc gacgagtacc tcgcggagcc gtcgctgccc gagttcttgg gagggaggtg ctatgcacag 
cctgcttgat cccacgttca acgggatgcc gggttcggag atgtaccggg gcgaagtgtt cccagagttg ttccccggca 
agcgaatgat gctcgagaac tggtcgcaag acgacctaga gcagtacgtc ggaggggtct tcacccccgg 
atatggaatg agaggagctg cgtgacagac accgaaatac cttgggggcc aacgggtgaa ctcgtctaca atcgtactta 
cgcacgaatc aagcctgatg gaacgcgtga gacgtggcca gagacagttc ggcgagtcgt ggacggcaat 
cttgcgcttg tgcctgagcg ataccaccag gacggggagc gcgaacagct cgtccgactg atggagcagt 
tcaagatcct gcccgccggc cggcacctgt gggccagcgg cgtgaagaac gcccagcacc tgttcaactg 
ctgggtgtcg ggatggcccg aggacatctc ggaccacttc cagttcactt tcatgcgcct gatggagggc 
gggggaagtc ggaagcgaac tactccaacc actacctcga gcactactcg cacgtcgtgc atcccctccg 
ggtcgagatc gtctgcgacc cagagcatgg tcgacctacc aggcgatgaa ggacgctggc atcctgtcga 
agcggtacga ctccgaatgg gcaggcgcgt tcccgatcga ggactcccgc gagggctggg ccaacgccct 
ggtcgacctg atcgacacgc actaccgacg cgacacggtcc acttcagccg ggtctacgac gtgagtcgta 
tccggcctgc cggggccaag ctcaagackt tcggtggatt cgccagcggg ccgctgccgt tcgctcagat gctgcag 
 
Figure 3.36 Sequence from clone 42 of Mozambique 3 PstI library with PstI site 
highlighted in orange. 
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BLASTn results 
The sequence was then analyzed using BLASTn to determine whether it shares any nucleotide sequence similarities with sequences in 
the database. 
 
  
Figure 3.37 BLASTn search result from clone 42 of Mozambique 3 PstI library when aligned with known sequences from the 
database.  
 
BLASTx results 
The sequence was also analyzed using BLASTx to determine whether it shares similarities with protein sequences in the database.  
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Figure 3.38 BLASTn search result from clone 42 of Mozambique 3 PstI library when 
aligned with known protein sequences from the database. 
 
ORF prediction and construction of restriction map 
Open reading frames were predicted using both GeneMark and SoftBerry, an ORF is 
accepted when there is a consensus between the results from the two programs. Clone 42 
has two ORFs, with ORF1 occupying the position from 492 to 674; ORF2 from 1125 to 
1367. A restriction map of the insert is drawn after analyzing the sequence using NEB 
cutter. The location of the three ORFs is also plotted on the map. This insert does not 
have any restriction sites that would allowing for subcloning in pDA71, with Sau3AI and 
TaqI being the only two endonuclease able to digest this insert. 
 
 
 
Figure 3.39 Restriction map of clone 42 of Mozambique 3 PstI library along with the 
positions of the two predicted ORFs 
 99 
BLASTp results of Clone 42 ORFs 
 
 
ORF1 
 
 
ORF2 
 
Figure 3.40 BLASTp search result of ORF 1 and 2 from clone 42 of Mozambique 3 PstI library when aligned with known protein 
sequences from the database.
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Ribonucleotide reductase (RNR) is essential to DNA synthesis and repair since it 
converts the 4 standard ribonucleotides to their 2’-deoxyribonleotide counterparts 
(Kolberg et al 2003). It is important to note that one such product, 5’-di/triphospho-2’-
deoxyuridine, is to be further processed and made into thymidine by TS, another enzyme 
essential to DNA synthesis. The importance of RNR is evident in its presence in every 
living organism (Jordan and Riechard 1998) and it could be suggested that certain 
viruses, including phages carry their own copy of the gene (and other genes that are 
indispensible to DNA synthesis) in order to ensure faster proliferation of viral genetic 
material in host cells (Kolberg et al 2003). 
 
RNR is divided into three classes based on the different metal co-factors that they utilize 
(Reichard 1993). However, all three classes share a cysteine residue which is converted 
into a thiyl radical that subtracts a hydrogen atom from its substrates (Eklund et al 2001). 
This radical is located in a protein loop that is shared by all three classes. This shows that 
all three classes of RNR share common ancestry with an ancient reductase (Kolberg et al 
2003). 
 
In phage T4, an anaerobic RNR, nrdD, has amino sequences similar to E. coli pyruvate 
formate-lyase (Pfl) (Young et al 1994). Both enzymes require radicals for their catalytic 
activity (in the case of Pfl, it synthesizes formate and acetyl-CoA from cleaving pyruvate) 
and both require an activating protein to function (for T4, it is gp55.9, for Pfl, it is Pfl 
activase) thus suggesting that both share common ancestry with an ancient anaerobic 
enzyme (Young et al 1994).  
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3.9.6 Clone 57 of Mozambique 3 PstI library 
 
Insert of clone 57 were extracted from a 0.6% agarose gel, purified, cloned into the PstI 
site of vector pUC18/19 vector and sequenced. The sequence is shown below 
 
ctgacaggcc ctggcgcssg twmattgraa tcccagcggg accgggtcga cgtatcgct gagagaacma 
caccacgctg aaggcttctc mggtggcggt gacgctcagg ctcgacccag caccgacctg ctggttctcg 
atgtagaacg tcgctgaggc gtgctccagc acgctctcgt ggccgacctc gaggatgtgg ttgaggtagt cctcgttctc 
cgctgtagcc gggttgggcc ggtcgaatga ccggtagcag ttccggcctg cgaactcggc tagctcgtcg 
gcatcgaagt cgccgaacgg gccgtcatcg tcgggctcgt tgaagatgtc gggctcgaac ccgatctccc 
gcagcgcatc cgggtcaacc tcggtggctg caatcagttt gactttcata ctctccgctc aragkgrgga ggaggggccg 
aagcccctcc cccggtggat gtcaagtacc gcgactactt cttgtcgttg aggtactgcg ccttgcactg ctggtcgcga 
ggtgcggtgc aggaraacag cttgtaggcg ttgcccgcct tgctgacgcc gctcttgaac accatctcgc cgtgctcaca 
gaaccgcttc tccccgttcg gagcctgctg cgccgcctgc ggcgcacgcg actgctgctg accgccgccg 
cccgcgttgc cggccggctt cgatyccgct gcgcggaggt gttcaccttc gccagaacgt cggccgggtc 
cagagccctt cacgaccacc cacgggtcgc tgtaagcgcc ccgcgaactt gaacgtggcc gacacccccg 
tcagtggagt gctggaccga caccgaatcg accgcagccg ccgaggcggt ggtcgctacc ggcgcggccg 
gctcakcctg agcgacgggc tcgggctcct gcgagggcgt accccaaggg ycttcgtagg acaaaattgc ttaccttttc 
acttaawggg gacatgcgcc gattggcgca ctcttcawtc gacammccgt tcttcrgacg ggcttttttg 
gcagcagcag attcgtactg ctgcttggtg attcgctcgt agggagcctg cgggaagctc gcctccggga 
agatcgtgga gcccttgatc agccccgcga acttctgcag 
 
Figure 3.41 Sequence of clone 57 from Mozambique 3 PstI library with PstI site 
highlighted in orange. 
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BLASTn results 
 
The sequence was then analyzed using BLASTn to determine whether it shares any nucleotide sequence similarities with sequences in 
the database. In the case of clone 57, segments of the insert is found to be similar to nucleotide sequences of mycobacteriophage 
Che12And Packman 
 
 
 
Figure 3.42 BLASTn search result from clone 57 of Mozambique 3 PstI library when aligned with known sequences from the 
database. 
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BLASTx results 
 
The sequence was also analyzed using BLASTx to determine whether it shares any similarities with protein sequences in the database.  
 
 
 
Figure 3.43 BLASTx search result from clone 57 of Mozambique 3 PstI library when aligned with known protein sequences from the 
database. 
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ORF prediction and construction of restriction map 
 
Open reading frames were predicted using both GeneMark and SoftBerry, an ORF is 
accepted when there is a consensus between the results from the two programs. Clone 57 
has two ORFs, with ORF1 occupying the position from 3 to 408; ORF2 from 474 to 758. 
A restriction map of the insert is also drawn after analyzing the sequence using NEB 
cutter. The positions of the three ORFs are also plotted on the map. 
 
 
Figure 3.44 Restriction map of clone 57 of Mozambique 3 PstI library along with the 
positions of the two predicted ORFs 
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BLASTp results of Clone 57 ORFs 
 
 
ORF1 
 
 
ORF2 
 
Figure 3.45 BLASTp search result of ORF 1 and 2 from clone 57 of Mozambique 3 PstI library when aligned with known protein 
sequences from the database
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Many of the predicted OFR did not have an assigned function, and as discussed above, 
many of the ORFs that have protein sequence similarity to those in the database are 
similar to those that are responsible for nucleotide production. This results, however, is 
also seen in another study on antimicrobial genes found in Rhodococcus phage YF1 
(Shibayama and Dabbs 2011). In this study, 13 ORFs from 10 clones (with sizes ranging 
from 390bp to 960bp) were predicted with only three having functions assigned to them. 
One such ORF also have protein sequence similarity to those of thymidylate synthase. 
Although it has been suggested above that the presence of genes that partake in DNA 
replication helps in phage DNA proliferation, thereby increasing transcription of phage 
genes (including antimicrobial ones) and increasing the pace of infection, Shibayama and 
Dabbs has also argued that TS could have been encoded by YF1 genes with the purpose 
of upsetting the balance of enzymes in thymidine production, thus interfering with host 
DNA replication.  
 
However, it is important to note that the enzymes discussed above are themselves 
antimicrobial targets for future drug development. As mentioned above, there are already 
several synthesized protein inhibitors for DNA primase and even one that is undergoing 
animal testing (Baumeister et al 2007), with TS being seen as another potential 
antimicrobial target (Matthews et al 2003). 
 
Since the genomic library of various phages was built using E. coli, none of the clones in 
this study would be inhibitory to E. coli. Hence the question remains whether or not all 
phage clones in the genomic library represents all the genes in the phage as any such 
genes that are inhibitory to E. coli would be lost. However, it is not clear if any of the 
phage genes are only inhibitory to Mycobacterium/Rhodococcus or do these genes simply 
fail to express themselves in E. coli (Shbayama and Dabbs 2011). In any case, since these 
genomic libraries were constructed using various restriction endonuclease, genes that 
could exhibit antimicrobial activates but are located at the ends of the genome will not be 
included, as the ends of the genome will not have compatible ends to be incorporated into 
either pUC18/19 or pDA71. 
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Table 3.16 Summary of screened clones and their predicted ORFs 
Clone # 
ORF 
# Start End Phage/Organism Function Protein size (aa) 
M1 clone 5 
 
1 1086 1496 L5 gp27 Minor tail subunit 38.5kd protein 127 
2 1503 1805 Trixie gp29 Minor tail subunit 100 
M1 clone 6 
 
1 2 79 Hammer gp37 Hypothesised parA protein - chromosome segregation 26 
2 184 351 N/A Unknown 55 
M3 clone 22 
 
 
 
1 1 310 Redrock gp46 
DNA polymerase I - 3'-5' exonuclease and polymerase 
domain 103 
2 319 483 Hammer gp49 Unknown 54 
3 476 658 Hammer gp49 Unknown 60 
4 1298 1596 Benedict gp44 
Thymidylate synthase complementing protein 
(ThyX/Thy1) 99 
M3 clone29 
 
 
1 56 184 N/A  Unknown 42 
2 471 617 Che12 gp63 Endonuclease VII; pfam02945 48 
3 614 760 Turbido gp61 DNA primase zinc binding motif 48 
M3 clone 42 
 
1 492 674 Turbido gp54 Unknown 60 
2 1125 1367 Che 12 gp53 Ribonucleotide reductase and pyruvate formate lyase 80 
M3 clone 57 
 
1 3 408 Pukovnik gp48 Unknown 135 
2 474 758 Gladiator gp50 Unknown 94 
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3.10 Yeast transformation 
 
Clones were selected to test for inhibitory activities in eukaryotes. There have been a 
number of researches done on the nature of antimicrobial activity of certain phage genes. 
Some of the genes target the replication mechanism and also transcription and replication 
apparatus of the cell, details of which have been discussed in the introduction above. 
Known inhibitory clones were transformed into S. cerevisiae to observe if these 
inhibitory clones can be expressed in yeast and whether if inhibitory activity can also be 
observed in eukaryotes. Should the activities be observed, it could shed light on the 
nature of phage gene products. Such genes could be involved in the disruption of cell 
DNA or RNA metabolism common in both prokaryotes and eukaryotes.  
 
Selected inserts from both PstI libraries of Mozambique 1 and Mozambique 3 was 
digested with PstI, ran on a 0.6% agarose gel, extracted from the gel and purified. These 
purified inserts were then ligated into pUC18/19 PstI site and transformed into E. coli 
MM294-4. New clones of pUC18/19 were then collected by mini plasmid preparations 
and screened for the presence inserts. These inserts were then digested with enzymes 
HindIII and XbaI and extracted from pUC18/19 in the same manner as they were 
extracted from PDA71. Inserts are then ligated into yeast vector pSHLeu, transformed 
again into E. coli MM294-4 and clones were again screened for the presence of inserts. 
These inserts are shown below after being released from the yeast vector after double 
digestion with HindIII and XbaI 
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            MW        1         2          3          4          5          6         7 
 
 
Figure 3.46 Inserts of clones from Mozambique 1 and 3 PstI libaries in yeast vector 
pSHLeu. Lane 1: clone 5 of PstI library of Mozambique 1; lane 2: clone 6 of 
Mozambique 1; lane 3: clone 22 of PstI library of Mozambique 3; lane 4: clone 29 of 
Mozambique 3; lane 5: clone 42; lane 6: clone 57 and lane 7: pSHLeu control 
 
Inserts in vector pSHLeu was then transformed into S. cerevisiae 
Size (bp) 
 
 
20000 → 
10000 → 
7000 → 
5000 → 
3000 → 
 
 
2000 → 
 
 
 
1500 → 
 
 
 
 
 
1000 → 
 
 
 
 
 
700 → 
 
 
 
 
 
500 → 
 
 
 
400 → 
 
 
 
 
300 → 
 
 
 
 
 
 
200 → 
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Clone 5 of Mozambique 1   Clone 6 of Mozambique 1 
   
Clone 22 of Mozambique 3               Clone 29 of Mozambique3 
 
         
Clone 42 of Mozambique 3      Clone 57 of Mozambique 3 
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pSHLeu control 
 
Fig 3.47 Transformation of S. cerevisiae by detected clones from PstI libraries of 
Mozambique 1 and Mozambique 3 along with vector only control 
 
Table 3.17 Transformation efficiencies of yeast transformation for selected clones 
isolated from Mozambique 1 and Mozambique 3 PstI libraries 
 
 
 
 
Clone # 
 
Transformants/μg of DNA 
5 20 
6 69 
22 18 
29 21 
42 12 
57 30 
pSHLeu Control 308 
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Clones tested in S. cerevisiae yielded much less colonies than those of the control, with 
the lowest figure being 12 transformants/μl of DNA for clone 42 while those of the 
control yielded 308 transformants/μl of DNA. However, when this is compared with the 
inhibitory figures from those of R. erythropolis, the highest figure of inhibition is 12.5 
transformants/μl of DNA, while its control yielded 1447 transformants/ μl of DNA. It is 
clear that when comparing the figures between the two transformations, the level of 
inhibition is observed to be much higher in R. erythropolis than in S. cerevisiae. 
Therefore, it could be argued that the clones do not exhibit inhibitory activities in S. 
cerevisiae, and that if it did, its effect is only partial and it is much less effective and 
much lower than those observed in R. erythropolis. 
 
Reasons for the lack of inhibitory activity observed can be suggested based on the protein 
similarities of various ORFs to those proteins in the database with known functions or 
structures. In the case of ORF1 and 2 of clone 5, the protein sequences of the two ORFs 
are similar to those of phage tail subunits. And as mentioned above, are related to phage 
tail like bacteriocins that are produced by bacteria. There has been no record of such 
bacteriocins having an inhibitory effect on eukaryotes. Since these tail like peptides are 
descended from defunct phages and all phages are known to only infect their particular 
niche of bacterial hosts, it is to be expected that these antimicrobial proteins to have no 
effect on S. cerevisiae. 
 
All other ORFs have protein similarity with proteins in the database that deals in DNA 
synthesis and metabolism, and unlike phage tail-like bacteriocins, such genes could be 
expected to display inhibitory activity towards S. cerevisiae. However, since the enzymes 
that are responsible for DNA synthesis are different between those found in eukaryotes 
and those in prokayotes, it is doubtful whether these ORFs, even if successfully 
expressed, will have much impact on S. cerevisiae. An example of this is the DNA 
primase: As discussed above, the structure of DNA primase found in T7 consists of one 
subunit with a single nucleotide binding site and two NTP binding sites (Kuchta and 
Stengel 2010) along with the ability to carry out helicase activity, while those in 
eukaryotes have two subunits and an iron-sulphur domain (Klinge et al 2007). In any 
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case, these phage genes have also failed to inhibit other prokaryotes, namely the E. coli 
host that was used to construct these genomic libraries. 
 
More experiments, such as a repeat of the transformation of S. cerecisiae, or testing 
individual subclones could shed more light into exact nature of the clones and help 
determine more accurately the level of inhibition if there are any. 
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4. Appendices 
 
Appendix A – Media and Solutions 
 
1 – Media 
 
LB 
  1g tryptone 
  0.5g sodium chloride 
  0.5g yeast extract 
  100ml dH2O 
 
LA 
  1g tryptone 
  0.5g sodium chloride 
  0.5 yeast extract 
  1.5g agar 
  100ml dH2O 
 
Sloppy agar 
  1g tryptone 
  0.5g sodium chloride 
  0.5 yeast extract 
  0.75g agar 
  100ml dH2O 
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LBSG 
  1g tryptone 
  0.5g sodium chloride 
  0.5g yeast extracts 
  10.3g sucrose 
  2g glycine 
  100ml dH2O 
 
Rhodococcus regeneration media 
  3g tryptone 
  0.9g sodium chloride 
  1.5g yeast extract 
  30.9g sucrose 
  1g glucose 
  1g magnesium chloride hexahydrate 
  250ml dH2O 
The mixture was heated in a microwave to dissolve the sucrose. 5.5g of agar was then 
added, autoclaved and cooled to 60
o
C and the following was added before being poured 
on a horizontal surface: 
  10ml 0.25 TES pH 7.2 
  6ml 1M calcium chloride 
  3ml 0.5% potassium dihydrogen orthophosphate 
  1.5 ml 10 mg/ml nystatin 
0.9 ml 10 mg/ml rifampicin 
 
YPD 
  2g peptone 
  1g yeast extract 
  2g glucose 
 
 
 116 
SC 
  1.34g yeast nitrogen base (without amino acids) 
  4g glucose 
  0.088 dropout mix 
  0.012g L-histidine 
  0.012g L-tryptophan 
  0.004g uracil 
 
Dropout mix 
  0.1g L-arginine 
  0.3g L-lysine 
  0.2g L-methionine 
  0.1g L-phenylalanine 
  0.3g L-serine 
  1.0g threonine 
  0.2g L-tyrosine 
  0.1g adenine 
Mixture was dissolved in 5L of dH2O 
 
1M Calcium chloride 
  2.2g calcium chloride 
  10ml dH2O 
 
1M Magnesium chloride 
  2.03g magnesium chloride 
  10ml dH2O 
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2 – Solutions for phage purification 
 
SC buffer 
  0.58 g sodium chloride 
0.2 g calcium chloride hexahydrate 
5 ml 1 M Tris-hydrochloride pH 8.0 
0.5 ml 2% gelatin 
95 ml dH2O 
 
2% Gelatin 
  0.02 g gelatin 
1 ml dH2O 
 
4.09g Cesium chloride was added to 5ml of SC buffer to achieve a density of 1.50g/ml. 
 
1 M Tris-hydrochloride pH 8.0 
  12.1g Tris base dissolved in 50ml dH2O 
  HCl added to adjust pH to 8.0 
  dH2O added to a final volume of 100ml 
 
3 – Solutions for Transmission Electron Microscopy 
 
0.35% Formvar 
  0.35g Formvar 
  100ml chloroform  
 
1% Uranyl acetate 
  0.05g uranyl acetate 
  5ml dH2O 
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4 – Solutions for phage DNA extraction 
 
Dialysis buffer  
  0.58g sodium chloride 
  2.2g calcium chloride hexahydrate 
  50ml 1M Tris-hydrochloride pH 8.0 
  950ml dH2O 
 
5 – Solutions for DNA manipulations 
 
Solution I 
  0.9g glucose 
  2.5ml 1M Tris-hydrochloride pH 8.0 
  2ml 0.5M EDTA pH 8.0 
  95.5ml dH2O 
 
Solution II 
  0.8g sodium hydroxide 
  1g SDS 
  100ml dH2O 
 
Solution III 
  60ml 5M sodium acetate 
  11.5ml glacial acetic acid 
  28.5ml dH2O 
 
0.5M EDTA pH 8.0 
  18.61g EDTA dissolved in 50ml of dH2O 
  Sodium hydroxide added to adjust pH to 8.0 
  dH2O added to a final volume of 100ml 
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TE buffer 
  1ml 1M Tris-hydrochloride pH 8.0 
  2ml 0.5M EDTA pH 8.0 
  97ml dH2O 
 
10% SDS 
  1g SDS 
  10ml dH2O 
1M Sodium chloride 
  0.58g Sodium chloride 
  10ml dH2O 
 
1% Ribonuclease 
  0.01g ribonuclease 
  1ml dH2O 
  Boil for 10 min 
 
6 – Solutions for electrophoresis 
 
5× TBE 
  54g Tris base 
  27.5g boric acid 
  20ml 0.5M EDTA pH 8.0 
  dH2O added to a final volume of 1000ml 
 
Running buffer 
  20ml 5× TBE 
  20μl 1% EtBr 
  200ml dH2O 
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Agarose gel 
  0.32g (for 0.8%), 0.24g (for 0.6%) agarose 
  4ml 5× TBE  
  36ml dH2O 
 
1% EtBr 
  0.1g EtBr 
  10ml dH2O 
 
Tracking Dye 
  0.01g bromophenol blue 
  0.01g xylene cyanol 
  10ml 30% glycerol in TE buffer 
 
7 – Solutions for Transformation 
 
Calcium transformation buffer 
  4.38g calcium chloride hexahydrate  
  2ml 1M Tris-hydrochloride pH 8.0 
  198ml dH2O 
 
Basal (B) buffer 
  10.3g glucose 
  0.025g potassium sulphate 
  0.202g magnesium chloride hexahydrate 
  10ml 0.25M TES pH 7.2 
  87.5ml dH2O 
 
 
 
 
 121 
Protoplast (P) buffer 
  2ml B buffer 
  20μl 0.5% potassium dihydrogen orthophosphate 
  50μl 1M calcium chloride 
 
P-PEG buffer 
  0.5g PEG 6000 UV sterilized for 10min 
  1ml P buffer 
  Vortexed vigorously to mix 
 
0.25 TES pH 7.2 
  17.2g TES in 250ml dH2O 
  Sodium hydroxide added to adjust pH to 7.2 
  dH2O added to a final volume of 300ml 
 
0.5% potassium dihydrogen orthophosphate 
  0.5g potassium dihydrogen orthophosphate 
  100ml dH2O 
 
1M Lithium acetate 
  6.56g lithium acetate 
   
50% PEG4000 
  0.5g PEG4000 
  1ml dH2O 
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8 – Antibiotics 
 
Table 4.1 List of antibiotics used  
Antibiotic Concentration (mg/ml) Solvent 
Ampicillin 100  70% ethanol 30% dH2O 
Chloramphenicol 4  ethanol 
Kanamycin 100 dH2O 
Nalidixic acid 100  70% ethanol 30% dH2O 
Nystatin 10  methanol 
Rifampicin 10  methanol 
Streptomycin 100  dH2O 
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Appendix B – Restriction Maps of Plasmids in this Study 
 
 
 
 
 
 
 
 
Figure 4.1 Restriction map of pDA71  
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Figure 4.2 Restriction map of pUC18/19 
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1 
 
 
 
2 
 
Figure 4.3 Multiple cloning sites of 1) pUC 18 and 2) pUC 19 
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Figure 4.4 Structure of pSHLeu and its multiple cloning sites. Unique restriction sites 
within the multiple cloning sites are underlined (adapted from Gan et al 2002) 
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Appendix C Molecular Weight Markers 
 
    
1       2 
 
Figure 4.5 Molecular weight markers of 1) New England Biolabs pulse field gel 
electrophoresis low range marker and 2) Fermentas GeneRuler 1kB plus DNA ladder 
 
Kb 
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Appendix D – Properties of Proteins with Sequence Similarities with Phage  
  Inibitory ORFs 
 
Table 4.2 Properties of L5 gp27 minor tail subunit 
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Table 4.3 Properties of Trixie gp29 minor tail subunit 
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 Table 4.4 Properties of Hammer gp37 parA-like protein 
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Table 4.5 Properties of Redrock gp46family A polymerase 
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Table 4.6 Properties of Benedict gp44 thymidylate synthase 
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Table 4.7 Properties of Che12 gp63endonuclease 
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Table 4.8 Properties of Turbido gp61DNA primase 
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Table 4.9 Properties of Che12 gp53Ribonucleotide reductase and pyruvate formate 
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